Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LAHO .How Can Stem Cell Treatment Help?
Stem cells may be able to reverse paralysis due to injury or stroke. The general mechanism is:
Doctors remove stem cells from the patient’s body or a donor’s body.
They culture those cells in a lab until they’ve reached a certain number, deemed large enough to prove effective when introduced into the patient’s body.
When that number is reached, physicians prep the patient and inject those stem cells into the affected part of the paralyzed victim.
They then observe the patient over the coming days, weeks, and months to check for reaction and monitor progress.
So, does it work? Some studies say yes.
Stem cells will 'change medicine forever,' says UB surgeon-turned-stem cell engineer
I gave up my whole surgery career to work on stem cell research.
..The potential is infinite with stem cells. It's regenerative medicine. Nearly all chronic disease in medicine could be addressed by stem cells. They will change medicine forever. Look at all the different pharmaceuticals patients are prescribed, sometimes for many years, ranging from blood thinners, to drugs to treat chronic pain. However, they are not ideal for treating chronic diseases, because they target a single molecular pathway, whereas curing chronic diseases would require targeting a multitude of pathways.
https://medicalxpress.com/news/2018-10-stem-cells-medicine-ub-surgeon-turned-stem.amp
Brings leadership in stem cell research, patient applications, and training to you through our state-of-the-art global network of companies. Our mission is to enable physicians to make the benefits of stem cell medicine a reality for patients around the world.
http://www.stemcellsgroup.com/
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells are the clearest opportunity to provide humans with a potentially life-saving solution in the future..Furthermore, the combination of private and public healthcare is the subject of current research, as is the development of new solutions and therapies...
Today, stem cells..are routinely used to treat approximately 80 medical conditions including leukaemia, lymphoma, immune disorders and anaemia. However, affordability and accessibility remain a challenge.
https://www.europeanceo.com/business-and-management/how-stem-cell-treatments-can-make-medicine-effective-and-affordable/
Stem cells: Creating a cure-all
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Stem Cells:
We are now in the earliest stages of stem cell therapy development. Future therapies will be transformative and, frankly, mind-boggling.
$LAHO GSCG FUTURE OF MEDICINE, REASONABLE, LOGICAL$$$$$$
$LAHO Regenerative medicine is far bigger than regenerative cell therapies alone
..in the USA alone was well in excess of 100 million patients
https://www.futuremedicine.com/doi/full/10.2217/rme.11.28?_sm_au_=&
GSCG..Adimarket..exosomes..FDA APPROVED
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
Mesenchymal stem cells for the treatment of neurodegenerative disease
MSCs transplanted into the brain have been demonstrated to promote functional recovery by producing trophic factors that induce survival and regeneration of host neurons. Therapies will capitalize on the innate trophic support from MSCs or on augmented growth factor support, such as delivering brain-derived neurotrophic factor or glial-derived neurotrophic factor into the brain to support injured neurons, using genetically engineered MSCs as the delivery vehicles. Clinical trials for MSC injection into the CNS to treat traumatic brain injury and stroke are currently ongoing
https://www.futuremedicine.com/doi/10.2217/rme.10.72
Our medical team adheres strictly to our inclusion and exclusion criteria.
..Patients Treatment +2000
Improvement and satisfaction 95%
Medical cases done 5000
http://cellgenic.com/our-story/#
http://cellgenic.com/articles/
We host training courses once a month in Sunrise, Florida and the fee to attend the course is $ 3500.
Online training $1500
https://www.stemcelltraining.net/faqs/
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
US health..spending increased 5.8%..3.2 Trillion
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Cell Culture Media Market
The global cell culture media market can now envision a leap from USD 703.1 million to USD 1290.1 million during the forecast period (2017-2023).
https://www.marketwatch.com/press-release/cell-culture-media-market-2018-assessment-industry-forecast-highlighting-growth-trends-up-to-2023-2018-10-11
Organ Repair/Regeneration
Over $60 billion in care annually is spent on these patients
http://www.bioquark.com/bioquantine-programs/bq-a-clinical-plans/
3D..worth over $30 billion by 2022
https://investingnews.com/daily/tech-investing/3d-printing-investing/top-3d-printing-companies/
Hair Transplant Market worth over $24.8 billion
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
Ophthalmologic stem cell transplantation therapies
The annual direct cost of medical care for the most prevalent eye disease, age-related macular degeneration, was estimated at US $255 billion in 2010 with an additional economic impact of US $88 billion due to lost productivity and the burden of family and community care for visual disability.
..demonstrate that stem cell-based transplants can preserve and potentially improve vision. This has led to new clinical trials for several eye diseases that are yielding encouraging results. In the next few years, additional trials and longer-term results are anticipated to further develop ocular regenerative therapies, with the potential to revolutionize our approach to ophthalmic disease and damage.
https://www.futuremedicine.com/doi/10.2217/rme.12.77
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Ophthalmologic therapies $343b
4 Tourism $179B
5 Organ repair $60B
6 3D printers $30B
7 Stem Bank $17.3B
8 Knee replacement?
9 ?
10 ?
$LAHO GSCG The future of Medicine, each sector worth Billions, printers, cosmetic, therapy, marketing, tourism, medical devices. Billions of dollars from big pharm will find the route to regenerative care. Best to measure against the market as seen fit$$$
$LAHO enjoyed reading your post today on longevity & stem curess$$
Cell therapy industry: billion dollar global business with unlimited potential
..Just as regenerative medicine is far bigger than regenerative cell therapies alone, cell therapies collectively represent a market opportunity many orders of magnitude greater than regenerative medicine
..It was estimated for 2009 that the potential market for all cell-based therapies in the USA alone was well in excess of 100 million patients
..More significantly, over 50% of these trials are at Phase II and III, the stages that begin to examine a therapeutic’s clinical effectiveness..
..Advanced BioHealing had revenues last year of $146 million..growth in revenues has gone from $44 million (2008) to $85 million (2009) to this year’s $146 million, with even more impressive gross profits of $28, $65 and $115 million for each respective year..
https://www.futuremedicine.com/doi/full/10.2217/rme.11.28?_sm_au_=
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150910262
Impressive growth above, though not as diverse as GSCG (blockchain, data, tech, certs, therapy) apply multiplexxx$$.
$LAHO GSCG Future of Medicine , reasonable, logical$$$
$LAHO Adimarket, LLC Looks to Expand Market Reach with Launch of New PRP Product
..“Adimarket and its products have been met with great enthusiasm from physicians in the US and Latin America,” said Benito Novas, CEO of the Global Stem Cells Group
http://www.stemcellsgroup.com/adimarket-llc-looks-to-expand-market-reach-with-launch-of-new-prp-product/
Rejuvenating brain stem cells may hold key to future MS treatments
https://www.medicalnewstoday.com/articles/amp/326066
Cambridge study reverses aging of key brain stem cells in rodents
https://newatlas.com/brain-stem-cells-opcs-reverse-aging-ms-cambridge/61063/
What’s next from stem cell research? Diabetes treatments and safer kidney transplants
https://geneticliteracyproject.org/2019/08/16/whats-next-from-stem-cell-research-diabetes-treatments-and-safer-kidney-transplants/
Forget..401(k)..Stem Cell Benefits May Let You Cheat Death
As MyCrypto mulled what benefits to offer employees, the new blockchain startup asked them what they wanted.
..A stem cell storage company that promises the chance for a longer and healthier life, Forever Labs asserts that young,
..“There’s not much downside to banking your own biology.”
https://www.bloomberg.com/news/articles/2018-08-27/companies-offer-employees-hope-with-stem-cell-storage-benefits
Why Big Pharma Is Diving Into Gene Therapy
Big Pharma has been struggling for years to produce drugs that are major breakthroughs in medicine. For these companies, gene therapy may be the promised land.
Gene therapy—treatments designed to replace faulty genes with healthy ones—offers potential cures for hundreds of genetic diseases, like hemophilia and muscular dystrophy.
https://www.barrons.com/articles/why-big-pharma-is-diving-into-gene-therapy-51551493752
$LAHO FUTURE OF MEDICINE, GOLD IS GOLD$$$$$$
$LAHO Cell therapy..unlimited potential
.. These FDA 510(k) approved (and/or CE mark in the EU) processing devices thus provide another route for cell therapy-based companies to supply the market.
Big Pharma: moving from exploration to exploitation of cell therapy?..There is no doubt that there has been a steady increase in the interest in the cell therapy sector from Big Pharma as well as the larger biotech and medical device companies
https://www.futuremedicine.com/doi/full/10.2217/rme.11.28?_sm_au_=iMVSr0vMv5MRs7gD&;
GLOBAL STEM CELLS GROUP TO LAUNCH FDA-REGISTERED SVF KITS AT THIS YEAR’S FIME EVENT
https://stemcellinc.in/global-stem-cells-group-to-launch-fda-registered-svf-kits-at-this-years-fime-event/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
$2,382.00 Cellgenic Amniotic Fluid-Human placental Derived
https://www.adimarket.net/product/cellgenic-pure-pro-cord-blood-derived/
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
$LAHO GSCG leader in regenerative care$$$$
$LAHO GSCG BILLION'S BY SEGEMENT, TRILLION DOLLAR MARKET$$
GSCG..positioning Adimarket to become..largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
We host training courses once a month in Sunrise, Florida and the fee to attend the course is $ 3500.
Online training $1500
https://www.stemcelltraining.net/faqs/
Our medical team adheres strictly to our inclusion and exclusion criteria.
..Patients Treatment
+2000
Improvement and satisfaction
95%
Medical cases done 5000
http://cellgenic.com/our-story/#
http://cellgenic.com/articles/
Brings leadership in stem cell research, patient applications, and training to you through our state-of-the-art global network of companies. Our mission is to enable physicians to make the benefits of stem cell medicine a reality for patients around the world.
http://www.stemcellsgroup.com/
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
Organ Repair/Regeneration
Over $60 billion in care annually is spent on these patients
http://www.bioquark.com/bioquantine-programs/bq-a-clinical-plans/
3D..worth over $30 billion by 2022
https://investingnews.com/daily/tech-investing/3d-printing-investing/top-3d-printing-companies/
Hair Transplant Market worth over $24.8 billion
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
US health..spending increased 5.8%..3.2 Trillion
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Cell Culture Media Market
The global cell culture media market can now envision a leap from USD 703.1 million to USD 1290.1 million during the forecast period (2017-2023).
https://www.marketwatch.com/press-release/cell-culture-media-market-2018-assessment-industry-forecast-highlighting-growth-trends-up-to-2023-2018-10-11
Medical Tourism Market Worth $179.6 Billion By 2026 CAGR: 21.9%
https://www.grandviewresearch.com/press-release/global-medical-tourism-market
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $30B
7 Knee replacement?
8 ?
9 ?
$LAHO GSCG The future of Medicine, each sector worth Billions, printers, cosmetic, therapy, marketing, tourism, medical devices. Billions of dollars from big pharm will find the route to regenerative care. Best to measure against the market as seen fit$$$
$LAHO likewise my friend, Stem cells & Blockchain Trillion dollar market$$$$
Stem Cells May Repair "Irreversible" Heart Damage
https://www.forbes.com/sites/stevensalzberg/2014/05/05/stem-cells-may-repair-irreversible-heart-damage/#4a1b7ce46033
Chasing a Cure for Lung Disease With Stem Cells: A Conversation With Finn Hawkins
You can take a cell from your skin, explained Darrell Kotton, MD, grow it in a dish, and then reprogram it to make a stem cell capable of becoming any cell type in the body. If you could succeed in turning those stem cells into functioning lung cells, Kotton went on, it could resolve a major bottleneck in pulmonology research — limited access to tissue samples — and accelerate a cure for cystic fibrosis and other diseases
https://www.bmc.org/healthcity/research/chasing-cure-lung-disease-stem-cells
Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine
The Goldman report discusses Samumed, a private RM company. With $300 million in funding,it’s valued at a staggering $12 billion Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c
Blankfein, Goldman Partners Hit Hamptons for Stem Cell Event
https://www.bloomberg.com/news/articles/2016-07-19/blankfein-goldman-partners-hit-hamptons-for-stem-cell-benefit
https://nyscf.org/wp-content/uploads/2008/03/3-13-08%20nysd%20-%20sls.pdf
$17.3 Bn Stem Cell Banking Market - Global Industry
https://www.prnewswire.com/news-releases/17-3-bn-stem-cell-banking-market---global-industry-trends-share-size-growth-opportunity-and-forecast-2019-2024--300816982.html
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Knee replacement?
8 ?
9 ?
$LAHO GSCG BLOCK CHAIN $1TRILLION MARKET STEM CELLS $1TRILLION DOLLAR MARKET FUTURE OF MEDICINE$$$$$$$$$$
$LAHO GSGC FUTURE OF MEDICINE$$$$$$$$$$
second-largest acquisition..history..$10 billion for a startup no one's heard of..Stemcentrx
https://www.businessinsider.com/why-abbvie-acquired-stemcentrx-2016-4
Stem Cells Lead To A Genuine Miracle Cure
https://www.forbes.com/sites/stevensalzberg/2017/11/13/transgenic-stem-cells-lead-to-a-genuine-miracle-cure/#6a1d8a4d5c52
Every year about 600,000 Americans get a knee replacement, a number that could rise to 3 million by 2030. Until recently, treatment options were either temporary or surgical.
Now, in numerous cases, stem cell therapy for knees is reducing pain and repairing cartilage. As a result, many people have been able to improve their quality of life and avoid surgery.
Side effects
Stem cell treatment for knees is noninvasive and rarely painful. Side effects are minimal.
https://www.healthline.com/health/stem-cell-therapy-for-knees#treatment
..We are committed to balancing competitive pricing and providing solid economic gains for our shareholders.
..We pledge to adhere to the highest standards of integrity on behalf of our customers, our stockholders, and the world. We have created the optimal corporate structure to realize Global Stem Cell Group’s long-term potential, and we have established the appropriate financial controls and management oversight of our internal processes.
http://www.stemcellsgroup.com/investor-relations
Brings leadership in stem cell research, patient applications, and training to you through our state-of-the-art global network of companies. Our mission is to enable physicians to make the benefits of stem cell medicine a reality for patients around the world.
http://www.stemcellsgroup.com/
Authorized Distributor of GMTN Exosome Injection and Other Biological Products..
Scientists believe that stem cell research can be used to treat medical conditions including Parkinson's disease, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis and rheumatoid arthritis.
http://www.stemcellsgroup.com/global-stem-cells-group-named-authorized-distributor-of-gmtn-exosome-injection-and-other-biological-products/
$LAHO GSCG EACH DIVISION WORTH PENNIES..COMBINED?$$$$
$LAHO Stem cells: Creating a cure-all
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents say all this groundwork is finally coming to fruition, others call progress slow and plodding.
.."I would say the pace of things has been much faster than I would have predicted," says Andy McMahon, PhD, a W.M. Keck provost and university professor at the University of Southern California.
In comparison, Wells says, prescription drugs often take 15 years to progress from research stages to market.
https://www.webmd.com/brain/news/20190812/stem-cells-and-health-advances-where-are-we-now
Medical Tourism Market Worth $179.6 Billion By 2026 CAGR: 21.9%
https://www.grandviewresearch.com/press-release/global-medical-tourism-market
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
Hair Transplant Market..to exceed USD 24.8 billion by 2024
https://www.marketwatch.com/press-release/hair-transplant-market-outlook-with-industry-review-and-forecasts-2019-04-02
..GSCG affiliate Adimarket announces the launch of the Cellgenic adipose-derived stem cell hair restoration application that maximizes the skin and hair follicles’ own revitalizing capabilities.
https://www.stemcelltraining.net/tag/stem-cells/page/2/
http://www.stemcellsgroup.com/prp-stem-cell-treatments-studied-hair-loss/hair-loss/
GSCG has signed an agreement with Dra. Caicedo, a specialist in hair loss treatment with an interest in delivering stem cell based treatments to her patients in Valencia.
https://www.globenewswire.com/news-release/2019/06/12/1867610/0/en/LAHO-Global-Stem-Cells-Group-Announces-Opening-of-Two-New-Stem-Cell-Centers.html
$LAHO GSCG FUTURE OF MEDICINE$$$$$$$$$$
$LAHO GSCG WELL RESPECTED BY MARKET RESEARCH GROUP.
https://www.facebook.com/people/Benito-Novas/100010042265337
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
For a limited time promotional shipping rates are available on most orders over $5000 .
H.I.F.U HIGH INTENSITY FOCUSED ULTRASOUND
$7500
https://www.adimarket.net/product-category/aesthetics-applications/
Stem cells are the clearest opportunity to provide humans with a potentially life-saving solution in the future..Furthermore, the combination of private and public healthcare is the subject of current research, as is the development of new solutions and therapies...
Today, stem cells..are routinely used to treat approximately 80 medical conditions including leukaemia, lymphoma, immune disorders and anaemia. However, affordability and accessibility remain a challenge.
https://www.europeanceo.com/business-and-management/how-stem-cell-treatments-can-make-medicine-effective-and-affordable/
We host training courses [b[color=red]]once a month in Sunrise, Florida[/color] and the fee to attend the course is $3500.
Online training $1500
https://www.stemcelltraining.net/faqs/
$LAHO FUTURE OF MEDICINE$$$$$$$$$$
$LAHO thanks Clay, thought I saw a gap around $.15 or $.18 while back?
cheers
$LAHO GSCG Office $167k per year, Top Location!!!
$23.95 /SF/Yr
6,982 SF
A Class “A” office building
Demographics Salary $95k
https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
For a limited time promotional shipping rates are available on most orders over $ 5000 .
H.I.F.U HIGH INTENSITY FOCUSED ULTRASOUND
$7500
https://www.adimarket.net/product-category/aesthetics-applications/
INTEGRATED STEM CELL WORKSTATION 150 in stock
https://www.adimarket.net/how-to-order/
JAPAN IN PROGRESS
http://stemcellslab.net/project-plan/
We host training courses once a month in Sunrise, Florida and the fee to attend the course is $ 3500.
Online training $1500
https://www.stemcelltraining.net/faqs/
$LAHO Adimarket medical devices can cost well over $5k..consider a full lab? Courses 3 levels $3500-1500 While supportive role may take online coure I would Imagine licensed staff in person$$$
Stem Cells May Repair "Irreversible" Heart Damage
https://www.forbes.com/sites/stevensalzberg/2014/05/05/stem-cells-may-repair-irreversible-heart-damage/#4a1b7ce46033
Blankfein, Goldman Partners Hit Hamptons for Stem Cell Event
https://www.bloomberg.com/news/articles/2016-07-19/blankfein-goldman-partners-hit-hamptons-for-stem-cell-benefit
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
$680k Trades!
https://ih.advfn.com/stock-market/USOTC/lans-holdings-inc-LAHO/stock-price
$LAHO GSCG GREAT DAY, SOON PARTY WITH BILLIONAIRES :) $$
$LAHO BILLIONAIRES POURING MONEY INTO STEM CELLS NO PROBLEM..
Stanford neurologist and longevity researcher Thomas Rando, MD, PhD and his colleagues have found that adult stem cells (those that hang around in mature tissues to facilitate tissue repair) have a surprising ability to notice, and respond, to damage in distant parts of the body. The researchers termed the response an "alert" state; the cells are no longer resting deeply, but are also not yet committed to possibly unnecessary action. (As I was writing our release, I kept envisioning the stem cells like dogs frozen in a point, waiting for further movement or instructions.)
https://scopeblog.stanford.edu/2014/06/02/alert-stem-cells-speed-damage-response-say-stanford-researchers/
Who Wants To Live Forever?..The Super-Rich, That's Who (And Most Everyone Else)
..Not only do many of the super-rich want immortality, but a good number of them are doing something about it. The likes of Sergey Brin, co-founder of Google, Larry Ellison, Co-founder of Oracle, and investor Peter Thiel are all putting money into ventures that are focused on extending the human life span.
..Hacking our DNA is another approach being taken. Our ability to use stem cells to cure disease is becoming increasingly an opportunity. Very possibly using stem cell technology, as well as modifications to our DNA, can result in significantly longer fruitful lives.
https://www.forbes.com/sites/russalanprince/2018/01/02/who-wants-to-live-forever-the-super-rich-thats-who-and-most-everyone-else/amp/
https://nyscf.org/wp-content/uploads/2008/03/3-13-08%20nysd%20-%20sls.pdf
GOLDMAN SACHS..Smart Money Is Piling Into Regenerative Medicine
Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine
The Goldman report discusses Samumed, a private RM company. With $300 million in funding,it’s valued at a staggering $12 billion Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c
.According to the American Cancer Society, one in three people will have cancer at some point in their lifetime
.. Surgical removal of tumors can be curative, but many tumors form so close to major blood vessels that surgery becomes challenging or impossible. That means the vast majority of cancer patients have to endure chemotherapy. Because chemotherapy can’t distinguish cancerous cells from healthy ones, it can cause a range of adverse side effects.
https://research.ncsu.edu/blog/2019/07/chancellors-innovation-fund-helps-turn-nc-state-research-into-real-world-solutions/
Exosomes, metastases, and the miracle of cancer stem cell markers
https://www.ncbi.nlm.nih.gov/pubmed/31030373
GSCG..Adimarket..exosomes..FDA APPROVED
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Hedgefund Mesoblast!
https://whalewisdom.com/stock/mblty
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
GLOBAL STEM CELLS GROUP AND WESTMINSTER UNIVERSITY IN KOREA AWARD CERTIFICATES
..Dr. Paul In Chan Chung personally handed each student his or her certificate.
“This was a monumental recognition ceremony for students who have gone above and beyond with regards our regenerative medicine lab-setting course,” said Novas. “We need more people to be committed to furthering the effects of stem cell medicine, and this batch of students is well on their way to contributing to the future of the industry.”
https://www.stemcelltraining.net/global-stem-cells-group-and-westminster-university-in-korea-award-certificates/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150827110
$LAHO GSCG BILLIONAIRES PARK THEIR BILLIONS..STEMCELLS$$
$LAHO ..How Can Stem Cell Treatment Help?
Stem cells may be able to reverse paralysis due to injury or stroke. The general mechanism is:
Doctors remove stem cells from the patient’s body or a donor’s body.
They culture those cells in a lab until they’ve reached a certain number, deemed large enough to prove effective when introduced into the patient’s body.
When that number is reached, physicians prep the patient and inject those stem cells into the affected part of the paralyzed victim.
They then observe the patient over the coming days, weeks, and months to check for reaction and monitor progress.
So, does it work? Some studies say yes.
Stem cells will 'change medicine forever,' says UB surgeon-turned-stem cell engineer
I gave up my whole surgery career to work on stem cell research.
..The potential is infinite with stem cells. It's regenerative medicine. Nearly all chronic disease in medicine could be addressed by stem cells. They will change medicine forever. Look at all the different pharmaceuticals patients are prescribed, sometimes for many years, ranging from blood thinners, to drugs to treat chronic pain. However, they are not ideal for treating chronic diseases, because they target a single molecular pathway, whereas curing chronic diseases would require targeting a multitude of pathways.
https://medicalxpress.com/news/2018-10-stem-cells-medicine-ub-surgeon-turned-stem.amp
https://www.businessinsider.com/why-abbvie-acquired-stemcentrx-2016-4
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota...a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
Brings leadership in stem cell research, patient applications, and training to you through our state-of-the-art global network of companies. Our mission is to enable physicians to make the benefits of stem cell medicine a reality for patients around the world.
http://www.stemcellsgroup.com/
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://time.com/5394912/stem-cell-treatment/?amp=true
$LAHO GSCG FUTURE OF MEDICINE, BIG PHARMA EMBRACING STEM-CELLS-SCIENCE$$$$$$$$$$$
$LAHO ADIMARKET SET TO SHARE INNOVATIVE EXOSOMES PRODUCTS AT UPCOMING MEDICAL CONGRESSES
The Adimarket and GSCG teams will continue their series of business trips to introduce Adimarket’s line of exosomes products to physicians across the globe. Currently, two additional business trips are on the docket where representatives will attend two upcoming medical congresses.
On September 25, 2019 GSCG faculty members will attend the 4th International Congress of Aesthetic Gynecology in Veracruz, Mexico to be held at the Holiday Inn Hotel. One faculty member will speak to the audience about the newest exosomes products and their clinical applications.
The GSCG will also be hosting the International Cell Therapy Symposium on the University of Miami campus in Miami, Florida on October 24, 2019. The event is expected to draw a large attendance of physicians in the regenerative medicine field, and the GSCG has invited more than 10 scientists and practitioners with vast experience in regenerative medicine to host the congress’ educational sessions. At least five of the conference sessions will focus on how exosomes can help people suffering from degenerative diseases
http://www.prunderground.com/adimarket-set-to-share-innovative-exosomes-products-at-upcoming-medical-congresses-2/00165031/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150860063
Doctors and scientists are excited about stem cells because they could help in many different areas of health and medical research. Studying stem cells may help explain how serious conditions such as birth defects and cancer come about. Stem cells may one day be used to make cells and tissues for therapy of many diseases. Examples include Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes, and arthritis.
https://medlineplus.gov/
..second-largest acquisition in the history of venture capital
AbbVie, a major biopharmaceutical company, just picked up biotech startup Stemcentrx in a deal that's worth up to $10.2 billion.
https://www.businessinsider.com/why-abbvie-acquired-stemcentrx-2016-4
ISSCA Set to Welcome 13 Speakers at Upcoming Symposium in Miami
http://www.stemcellsgroup.com/13-speakers-at-upcoming-symposium-in-miami/
Stem Cell Transplants in Cancer Treatment
Stem cell transplants help restore blood-forming stem cells in people who have had theirs destroyed by certain cancer treatments.
Credit: National Cancer Institute
Stem cell transplants are procedures that restore blood-forming stem cells in people who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy that are used to treat certain cancers.
https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
$LAHO GSCG EACH DIVISION WORTH PENNIES,.. COMBINED??$$
$LAHO.. StemCells Trillion-Dollar..BOFA, Goldman Conservative $600 Billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
The Trillion-Dollar Longevity Industry
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
https://www.inc.com/james-paine/3-industries-that-will-probably-create-the-first-trillionaire.html
https://www.nanalyze.com/2019/08/top-10-companies-longevity
US health..spending increased 5.8%..3.2 Trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Adimarket import.. 40 FOOT CONTAINER South Korea
Adimarker Llc imports from N-biotek, Inc. in South Korea through the port of Los Angeles, California
..DESCRIPTION CENTRIFUGES FOR LABORATORY USE 8421.19-1000
..SUPPLIER N-BIOTEK, INC.
https://www.importgenius.com/importers/adimarket-llc
Supplier N-Biotek $8.4M
Adimarket announce agreement.. N-Biotek to offer the Total Solution highly manipulated stem cell culture expansion lab, complete with equipment, training, facilities, stem cell processing center, clean rooms, project plan and more- a total turnkey lab solution for emerging stem cell businesses and industry professionals.
The announcement marks a new chapter in GSCG’s ongoing expansion, and commitment to bring stem cell therapies..
..Until now, Admarket has been GSCG’s online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals, offering basic tools and products to facilitate in-office stem cell procedures. However, through N-Biotek, Adimarket now offers the Total Solution labs and all the accoutrements. From planning to building the facility, to training and consultation, Total Solution users are equipped in every way possible to walk in and begin using their fully-equipped biotechnology lab in short order.
https://www.stemcelltraining.net/total-solution/
http://stemcellcenter.net/
N-Biotek History
http://www.n-biotek.com/index.php?module=Board&action=SiteBoard&iBrdNo=9&sMode=SELECT_FORM
Clinical trials news
http://www.mesenchymalcellnews.com/issue/volume-8-34-aug-30/
Product Catalog!
http://n-biotek.com/N-BIOTEK_PRODUCT_CATALOG_VOL_18.pdf
GSCG is #1 Competitor for Biostems Tech $1.52 Dark Defunct!
GCSG is #1 competitor for Beike Biotechnology.
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
GSCG is #1 competitor Global Institute Of Stem Cell Therapy And Research!
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
GSCG TREATING FORMER NFL PRO!
$LAHO Much appreciated, followed back.
Welcome to the Global Stem Cells Group website! GSCG is a group of companies, each dedicated to facilitating stem cell research and medicine.
Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
http://www.stemcellsgroup.com/our-story/
GSCG QATAR
GSCG Costa Rica
GSGC CHILE & ARGENTINA
GSGC MEXICO
SOUTH KOREA
https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473
https://twitter.com/StemCellGroupUS
GSCG Office $167k per year, Top Location!!!
$23.95 /SF/Yr
6,982 SF
A Class “A” office building
Demographics Salary $95k
https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
http://www.lans.holdings/
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Stem cells: THE FUTURE OF MEDICINE
Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp
$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
The Smart Money Is Piling Into Regenerative Medicine
Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine
The Goldman report discusses Samumed, a private RM company. With $300 million in funding, [b[color=red]]it’s valued at a staggering $12 billion[/color]. Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
$LAHO Venture-capital investors.. pouring money..regenerative medicine.
Goldman Sachs defines regenerative medicine as approaches that grow cells or tissue from stem cells, treatments that promote regeneration, or transplants using organs or tissue grown outside the body.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
Goldman Sachs highlighted..$12 billion private biotech startup that wants to regenerate hair, skin, bones, and joints, and Unity Biotechnology, which is working on treatments that act on senescent cells.
Money is pouring in to a hot new area of science that could change the way we think about aging
.."We believe companies backed by academic pioneers ... or those with novel platforms ... are likely to garner the largest investments and valuations," the report said.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
$LAHO Blankfein, Goldman Partners Hit Hamptons for Stem Cell Event
https://www.bloomberg.com/news/articles/2016-07-19/blankfein-goldman-partners-hit-hamptons-for-stem-cell-benefit
These are the students Goldman Sachs REALLY wants to hire
..37% of the analysts hired by Goldman Sachs last year were STEM majors according to Blankfein.
https://news.efinancialcareers.com/uk-en/273366/goldman-sachs-stem-students
https://www.goldmansachs.com/search/search.gscgi?query=STEM+CELLS
Cancer Biotech Firm Alpha Tau Medical Appoints Raphi Levy of Goldman Sachs as Chief Financial Officer
https://www.prnewswire.com/news-releases/cancer-biotech-firm-alpha-tau-medical-appoints-raphi-levy-of-goldman-sachs-as-chief-financial-officer-300818388.html
Lloyd Blankfein, the CEO of Goldman Sachs, announced on Tuesday that he has lymphoma..Stem cell transplantation could also be used as a treatment.
https://fortune.com/2015/09/22/lymphoma/
https://www.issca.us/
http://stemcellcenter.net/center/quito/
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
Stem cells are the clearest opportunity to provide humans with a potentially life-saving solution in the future..Furthermore, the combination of private and public healthcare is the subject of current research, as is the development of new solutions and therapies...
Today, stem cells..are routinely used to treat approximately 80 medical conditions including leukaemia, lymphoma, immune disorders and anaemia. However, affordability and accessibility remain a challenge.
https://www.europeanceo.com/business-and-management/how-stem-cell-treatments-can-make-medicine-effective-and-affordable/
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
Medical Tourism Market Worth $179.6 Billion By 2026 CAGR: 21.9%
https://www.grandviewresearch.com/press-release/global-medical-tourism-market
Stem cells: Creating a cure-all
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents say all this groundwork is finally coming to fruition, others call progress slow and plodding.
.."I would say the pace of things has been much faster than I would have predicted," says Andy McMahon, PhD, a W.M. Keck provost and university professor at the University of Southern California.
In comparison, Wells says, prescription drugs often take 15 years to progress from research stages to market.
https://www.webmd.com/brain/news/20190812/stem-cells-and-health-advances-where-are-we-now
US health..spending increased 5.8%..3.2 Trillion
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Cancer Reversion
Despite spending close to a trillion dollars in the “war on cancer” to date, the disease remains one of our major killers.
Organ Repair/Regeneration
Over $60 billion in care annually is spent on these patients, when only taking into account the costs of dialysis and kidney transplants
www.bioquark.com/bioquantine-programs/bq-a-clinical-plans/
At current rates, by 2025, nearly ¼ of the US GDP will be spent on healthcare.
It takes on average 12 years and $359 million to take a new drug from the lab to a patient.
Only 5 in 5,000 of these new drugs make it to human testing. From there, only 1 of those 5 is actually approved for human use.
And Now, the Good News:
We are in the midst of a (medical) revolution driven by exponential technology: artificial intelligence, sensors, robotics, 3D printing, big data, genomics and stem cells.
Today’s $3.8 trillion dollar healthcare industry is in the deceptive phase of its march towards dematerialization, demonetization and democratization (as I discuss in my A360 Summits).
Stem Cells:
We are now in the earliest stages of stem cell therapy development. Future therapies will be transformative and, frankly, mind-boggling.
Stem cell therapy promises tissue regeneration and renewal – and thus a “cure” for everything from blindness to spinal cord injuries, type 1 diabetes, Parkinson’s disease, Alzheimer’s disease, heart disease, stroke, burns, cancer and osteoarthritis.
In 2012, researchers at Cedars-Sinai reported one of the first cases of successful therapeutic stem cell treatment – they used patients’ own stem cells to regenerate heart tissue and undo damage from a heart attack.
https://www.diamandis.com/blog/life-or-death
$17.3 Bn Stem Cell Banking Market - Global Industry..CAGR of 13.5%
https://www.prnewswire.com/news-releases/17-3-bn-stem-cell-banking-market---global-industry-trends-share-size-growth-opportunity-and-forecast-2019-2024--300816982.html
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Knee replacement?
8 ?
9 ?
$LAHO GSCG ALL THESE BILLION DOLLAR SEGMENTS ADDING UP$$$$
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World
What Does Pfizer Have to do with the World of Stem Cells?
Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
CONSUMER REPORT..stem cells market. a whole lot of demand
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
The power to print money.
Trillions of dollars – on-demand.[/color]
..For the first time in history - central banks are now funneling trillions of dollars, directly into the stock market.
The Swiss National Bank is on a buying spree – adding hundreds of thousands of shares of Ford, Xcel Energy, Costco, and many other American companies to its portfolio in the last few months.
According to Bloomberg, The Bank of Japan is now the #1 buyer of Japanese stocks. And if their buying binge continues – within a few years, they could own the ENTIRE market!
China's Central bank – the world's largest central bank, worth more than $5.4 trillion -- is now a Top 10 shareholder in the biggest, most well-known stocks in Shanghai.
https://orders.thecrux.com/chain?cid=MKT376375&eid=MKT417624&step=start&assetId=AST90728&page=1
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150726448
Amag Pharma..buy world's largest stem..bank..$700 million
..and that it was on the hunt for more deals.
https://www.globenewswire.com/news-release/2015/06/29/748090/10139996/en/AMAG-Pharmaceuticals-to-Acquire-Cord-Blood-Registry.html
In 2018, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market..
https://www.globenewswire.com/news-release/2019/07/16/1883226/0/en/Global-Cell-Culture-Market-Outlook-Report-2019-2024-Pharmaceutical-Biotechnology-Companies-are-Expected-to-Dominate.html
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Harvard team grows cyborg mini-organs out of stem cells
https://newatlas.com/cyborg-organoids-mini-organs-sensors/61006/
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
Stem Cells Are Poised to Change Health and Medicine Forever
Transplanted cells offer middle-aged rodents an increased life span
https://www.scientificamerican.com/article/brains-stem-cells-slow-aging-in-mice/
Bone Marrow Transplants Increase Healthy Lifespan in Mice
Stem Cell Start-up Could Extend Lifespan by Decades
Will 100 be the new 60?
https://wallstreetpit.com/114544-stem-cell-extend-lifespan-decades/
..The new biotech initiative whose board includes former Apple CEO John Sculley, ex-FDA commissioner Andrew Von Eschenbach and founder of Alphabet’s venture capital arm Bill Maris, is built around the idea that stem cells found in postpartum human placentas are ideal for regenerating damaged and aged tissue
https://wallstreetpit.com/114544-stem-cell-extend-lifespan-decades/
https://www.google.com/amp/s/singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/amp/
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Johns Hopkins
The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done
https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-
with-stem-cells
For a limited time promotional shipping rates are available on most orders over $ 5000 .
https://www.adimarket.net/how-to-order/
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Hair Transplant Market worth over $24.8 billion by 2024:
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
$LAHO..US health..spending increased 5.8% to..USD 3.2 Trillion trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Who Wants To Live Forever?..The Super-Rich, That's Who (And Most Everyone Else)
..Not only do many of the super-rich want immortality, but a good number of them are doing something about it. The likes of Sergey Brin, co-founder of Google, Larry Ellison, Co-founder of Oracle, and investor Peter Thiel are all putting money into ventures that are focused on extending the human life span.
..Hacking our DNA is another approach being taken. Our ability to use stem cells to cure disease is becoming increasingly an opportunity. Very possibly using stem cell technology, as well as modifications to our DNA, can result in significantly longer fruitful lives.
https://www.forbes.com/sites/russalanprince/2018/01/02/who-wants-to-live-forever-the-super-rich-thats-who-and-most-everyone-else/amp/
Anti-aging and the billionaires young blood & stem cell club
https://ipscell.com/2018/09/anti-aging-and-the-billionaires-young-blood-stem-cell-club/
https://www.nextbigfuture.com/2018/08/80-year-old-billionaires-are-injecting-placental-stem-cells-to-boost-lifespan-and-health.html?amp
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
Venture capital investments..record.. $207 billion
https://singularityhub.com/2019/08/20/these-are-the-meta-trends-shaping-the-future-at-breakneck-speed/
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Stem Cells Lead To A Genuine Miracle Cure
Exosomes, metastases, and the miracle of cancer stem cell markers
https://www.ncbi.nlm.nih.gov/pubmed/31030373
Stem Cell Treatment Could Be a Game-Changer for People With MS
https://time.com/5205946/stem-cell-treatment-multiple-sclerosis-patients/
On the immortality of stem cells
University of Cologne
Summary: Stem cells are considered to be immortal in culture and, therefore, of great interest for aging research. This immortality is regulated by increased proteostasis, which controls the quality of proteins. A team of researchers found a link between increased proteostasis and immortality of human embryonic stem cells
https://www.sciencedaily.com/releases/2018/03/180307101033.htm
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
$2,382.00 Cellgenic Amniotic Fluid-Human placental Derived
https://www.adimarket.net/product/cellgenic-pure-pro-cord-blood-derived/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
CELLGENIC
http://cellgenic.com
https://www.adimarket.net/product/cellgenic-pure-cord-blood-derived/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
NASA and Techshot Trying To 3D Print Organs In Space
https://www.nasa.gov/mission_pages/station/research/news/spx18-research
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D Bioprinting Market To Reach USD 4.40 Billion
.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://www.linkedin.com/company/lans-holdings-inc
https://www.linkedin.com/in/dave-christensen-b38a82
http://www.lans.holdings
https://www.linkedin.com/company/tnt-blockchain
$1.37 per share..TNT Blockchain is led by President David Christensen
https://www.zkinternationalgroup.com/xsigma-corporation
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
Aesthetic Marketing Group Announces the First International Meeting on Marketing in Aesthetic Medicine
https://www.prunderground.com/aesthetic-marketing-group-announces-the-first-international-meeting-on-marketing-in-aesthetic-medicine/00124178/
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
LAB FACILITY AND EQUIPMENT
http://stemcellslab.net/facility-and-equipment/
JAPAN IN PROGRESS
http://stemcellslab.net/project-plan/
GSCG Provider Testimonials
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150433068
BUSINESS OPPORTUNITY
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
BENITO GLOBAL TRAVELS-PARTNERS FROM Kuwait TO CHILE
Medicel Stem Cell Laboratory Visit Santiago Chile
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile
http://adimarket.info/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
VidaCel Chile.
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Cell Culture Media $1.2B
8 Knee replacement?
9 ?
$LAHO GSCG..REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH. GOLDMAN SACH'S, BILLIONAIRES PURING MONEY INTO STEM CELLS. GSCG.. EACH DIVISION OF GSCG COULD RUN TO PENNIES..COMBINED?
QUOD ERAT DEMONSTRANDUM GLTA
$LAHO..BOFA, Goldman Conservative $600 Billion, Trillion dollar longevity market
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
The Trillion-Dollar Longevity Industry
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
https://www.inc.com/james-paine/3-industries-that-will-probably-create-the-first-trillionaire.html
https://www.nanalyze.com/2019/08/top-10-companies-longevity
US health..spending increased 5.8%..3.2 Trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Adimarket import.. 40 FOOT CONTAINER South Korea
Adimarker Llc imports from N-biotek, Inc. in South Korea through the port of Los Angeles, California
..DESCRIPTION CENTRIFUGES FOR LABORATORY USE 8421.19-1000
..SUPPLIER N-BIOTEK, INC.
https://www.importgenius.com/importers/adimarket-llc
Supplier N-Biotek $8.4M
Adimarket announce agreement.. N-Biotek to offer the Total Solution highly manipulated stem cell culture expansion lab, complete with equipment, training, facilities, stem cell processing center, clean rooms, project plan and more- a total turnkey lab solution for emerging stem cell businesses and industry professionals.
The announcement marks a new chapter in GSCG’s ongoing expansion, and commitment to bring stem cell therapies..
..Until now, Admarket has been GSCG’s online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals, offering basic tools and products to facilitate in-office stem cell procedures. However, through N-Biotek, Adimarket now offers the Total Solution labs and all the accoutrements. From planning to building the facility, to training and consultation, Total Solution users are equipped in every way possible to walk in and begin using their fully-equipped biotechnology lab in short order.
https://www.stemcelltraining.net/total-solution/
http://stemcellcenter.net/
N-Biotek History
http://www.n-biotek.com/index.php?module=Board&action=SiteBoard&iBrdNo=9&sMode=SELECT_FORM
Clinical trials news
http://www.mesenchymalcellnews.com/issue/volume-8-34-aug-30/
Product Catalog!
http://n-biotek.com/N-BIOTEK_PRODUCT_CATALOG_VOL_18.pdf
GSCG is #1 Competitor for Biostems Tech $1.52 Dark Defunct!
GCSG is #1 competitor for Beike Biotechnology.
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
GSCG is #1 competitor Global Institute Of Stem Cell Therapy And Research!
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
GSCG TREATING FORMER NFL PRO!
$LAHO Much appreciated, followed back.
Welcome to the Global Stem Cells Group website! GSCG is a group of companies, each dedicated to facilitating stem cell research and medicine.
Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
http://www.stemcellsgroup.com/our-story/
GSCG QATAR
GSCG Costa Rica
GSGC CHILE & ARGENTINA
GSGC MEXICO
SOUTH KOREA
https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473
https://twitter.com/StemCellGroupUS
GSCG Office $167k per year, Top Location!!!
$23.95 /SF/Yr
6,982 SF
A Class “A” office building
Demographics Salary $95k
https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
http://www.lans.holdings/
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Stem cells: THE FUTURE OF MEDICINE
Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp
$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
The Smart Money Is Piling Into Regenerative Medicine
Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine
The Goldman report discusses Samumed, a private RM company. With $300 million in funding, [b[color=red]]it’s valued at a staggering $12 billion[/color]. Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
$LAHO Venture-capital investors.. pouring money..regenerative medicine.
Goldman Sachs defines regenerative medicine as approaches that grow cells or tissue from stem cells, treatments that promote regeneration, or transplants using organs or tissue grown outside the body.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
Goldman Sachs highlighted..$12 billion private biotech startup that wants to regenerate hair, skin, bones, and joints, and Unity Biotechnology, which is working on treatments that act on senescent cells.
Money is pouring in to a hot new area of science that could change the way we think about aging
.."We believe companies backed by academic pioneers ... or those with novel platforms ... are likely to garner the largest investments and valuations," the report said.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
$LAHO Blankfein, Goldman Partners Hit Hamptons for Stem Cell Event
https://www.bloomberg.com/news/articles/2016-07-19/blankfein-goldman-partners-hit-hamptons-for-stem-cell-benefit
These are the students Goldman Sachs REALLY wants to hire
..37% of the analysts hired by Goldman Sachs last year were STEM majors according to Blankfein.
https://news.efinancialcareers.com/uk-en/273366/goldman-sachs-stem-students
https://www.goldmansachs.com/search/search.gscgi?query=STEM+CELLS
Cancer Biotech Firm Alpha Tau Medical Appoints Raphi Levy of Goldman Sachs as Chief Financial Officer
https://www.prnewswire.com/news-releases/cancer-biotech-firm-alpha-tau-medical-appoints-raphi-levy-of-goldman-sachs-as-chief-financial-officer-300818388.html
Lloyd Blankfein, the CEO of Goldman Sachs, announced on Tuesday that he has lymphoma..Stem cell transplantation could also be used as a treatment.
https://fortune.com/2015/09/22/lymphoma/
https://www.issca.us/
http://stemcellcenter.net/center/quito/
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
Stem cells are the clearest opportunity to provide humans with a potentially life-saving solution in the future..Furthermore, the combination of private and public healthcare is the subject of current research, as is the development of new solutions and therapies...
Today, stem cells..are routinely used to treat approximately 80 medical conditions including leukaemia, lymphoma, immune disorders and anaemia. However, affordability and accessibility remain a challenge.
https://www.europeanceo.com/business-and-management/how-stem-cell-treatments-can-make-medicine-effective-and-affordable/
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
Medical Tourism Market Worth $179.6 Billion By 2026 CAGR: 21.9%
https://www.grandviewresearch.com/press-release/global-medical-tourism-market
Stem cells: Creating a cure-all
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents say all this groundwork is finally coming to fruition, others call progress slow and plodding.
.."I would say the pace of things has been much faster than I would have predicted," says Andy McMahon, PhD, a W.M. Keck provost and university professor at the University of Southern California.
In comparison, Wells says, prescription drugs often take 15 years to progress from research stages to market.
https://www.webmd.com/brain/news/20190812/stem-cells-and-health-advances-where-are-we-now
US health..spending increased 5.8%..3.2 Trillion
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Cancer Reversion
Despite spending close to a trillion dollars in the “war on cancer” to date, the disease remains one of our major killers.
Organ Repair/Regeneration
Over $60 billion in care annually is spent on these patients, when only taking into account the costs of dialysis and kidney transplants
www.bioquark.com/bioquantine-programs/bq-a-clinical-plans/
At current rates, by 2025, nearly ¼ of the US GDP will be spent on healthcare.
It takes on average 12 years and $359 million to take a new drug from the lab to a patient.
Only 5 in 5,000 of these new drugs make it to human testing. From there, only 1 of those 5 is actually approved for human use.
And Now, the Good News:
We are in the midst of a (medical) revolution driven by exponential technology: artificial intelligence, sensors, robotics, 3D printing, big data, genomics and stem cells.
Today’s $3.8 trillion dollar healthcare industry is in the deceptive phase of its march towards dematerialization, demonetization and democratization (as I discuss in my A360 Summits).
Stem Cells:
We are now in the earliest stages of stem cell therapy development. Future therapies will be transformative and, frankly, mind-boggling.
Stem cell therapy promises tissue regeneration and renewal – and thus a “cure” for everything from blindness to spinal cord injuries, type 1 diabetes, Parkinson’s disease, Alzheimer’s disease, heart disease, stroke, burns, cancer and osteoarthritis.
In 2012, researchers at Cedars-Sinai reported one of the first cases of successful therapeutic stem cell treatment – they used patients’ own stem cells to regenerate heart tissue and undo damage from a heart attack.
https://www.diamandis.com/blog/life-or-death
$17.3 Bn Stem Cell Banking Market - Global Industry..CAGR of 13.5%
https://www.prnewswire.com/news-releases/17-3-bn-stem-cell-banking-market---global-industry-trends-share-size-growth-opportunity-and-forecast-2019-2024--300816982.html
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Knee replacement?
8 ?
9 ?
$LAHO GSCG ALL THESE BILLION DOLLAR SEGMENTS ADDING UP$$$$
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World
What Does Pfizer Have to do with the World of Stem Cells?
Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
CONSUMER REPORT..stem cells market. a whole lot of demand
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
The power to print money.
Trillions of dollars – on-demand.[/color]
..For the first time in history - central banks are now funneling trillions of dollars, directly into the stock market.
The Swiss National Bank is on a buying spree – adding hundreds of thousands of shares of Ford, Xcel Energy, Costco, and many other American companies to its portfolio in the last few months.
According to Bloomberg, The Bank of Japan is now the #1 buyer of Japanese stocks. And if their buying binge continues – within a few years, they could own the ENTIRE market!
China's Central bank – the world's largest central bank, worth more than $5.4 trillion -- is now a Top 10 shareholder in the biggest, most well-known stocks in Shanghai.
https://orders.thecrux.com/chain?cid=MKT376375&eid=MKT417624&step=start&assetId=AST90728&page=1
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150726448
Amag Pharma..buy world's largest stem..bank..$700 million
..and that it was on the hunt for more deals.
https://www.globenewswire.com/news-release/2015/06/29/748090/10139996/en/AMAG-Pharmaceuticals-to-Acquire-Cord-Blood-Registry.html
In 2018, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market..
https://www.globenewswire.com/news-release/2019/07/16/1883226/0/en/Global-Cell-Culture-Market-Outlook-Report-2019-2024-Pharmaceutical-Biotechnology-Companies-are-Expected-to-Dominate.html
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Harvard team grows cyborg mini-organs out of stem cells
https://newatlas.com/cyborg-organoids-mini-organs-sensors/61006/
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
Stem Cells Are Poised to Change Health and Medicine Forever
Transplanted cells offer middle-aged rodents an increased life span
https://www.scientificamerican.com/article/brains-stem-cells-slow-aging-in-mice/
Bone Marrow Transplants Increase Healthy Lifespan in Mice
Stem Cell Start-up Could Extend Lifespan by Decades
Will 100 be the new 60?
https://wallstreetpit.com/114544-stem-cell-extend-lifespan-decades/
..The new biotech initiative whose board includes former Apple CEO John Sculley, ex-FDA commissioner Andrew Von Eschenbach and founder of Alphabet’s venture capital arm Bill Maris, is built around the idea that stem cells found in postpartum human placentas are ideal for regenerating damaged and aged tissue
https://wallstreetpit.com/114544-stem-cell-extend-lifespan-decades/
https://www.google.com/amp/s/singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/amp/
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Johns Hopkins
The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done
https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-
with-stem-cells
For a limited time promotional shipping rates are available on most orders over $ 5000 .
https://www.adimarket.net/how-to-order/
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Hair Transplant Market worth over $24.8 billion by 2024:
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
$LAHO..US health..spending increased 5.8% to..USD 3.2 Trillion trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Who Wants To Live Forever?..The Super-Rich, That's Who (And Most Everyone Else)
..Not only do many of the super-rich want immortality, but a good number of them are doing something about it. The likes of Sergey Brin, co-founder of Google, Larry Ellison, Co-founder of Oracle, and investor Peter Thiel are all putting money into ventures that are focused on extending the human life span.
..Hacking our DNA is another approach being taken. Our ability to use stem cells to cure disease is becoming increasingly an opportunity. Very possibly using stem cell technology, as well as modifications to our DNA, can result in significantly longer fruitful lives.
https://www.forbes.com/sites/russalanprince/2018/01/02/who-wants-to-live-forever-the-super-rich-thats-who-and-most-everyone-else/amp/
Anti-aging and the billionaires young blood & stem cell club
https://ipscell.com/2018/09/anti-aging-and-the-billionaires-young-blood-stem-cell-club/
https://www.nextbigfuture.com/2018/08/80-year-old-billionaires-are-injecting-placental-stem-cells-to-boost-lifespan-and-health.html?amp
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
Venture capital investments..record.. $207 billion
https://singularityhub.com/2019/08/20/these-are-the-meta-trends-shaping-the-future-at-breakneck-speed/
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Stem Cells Lead To A Genuine Miracle Cure
Exosomes, metastases, and the miracle of cancer stem cell markers
https://www.ncbi.nlm.nih.gov/pubmed/31030373
Stem Cell Treatment Could Be a Game-Changer for People With MS
https://time.com/5205946/stem-cell-treatment-multiple-sclerosis-patients/
On the immortality of stem cells
University of Cologne
Summary: Stem cells are considered to be immortal in culture and, therefore, of great interest for aging research. This immortality is regulated by increased proteostasis, which controls the quality of proteins. A team of researchers found a link between increased proteostasis and immortality of human embryonic stem cells
https://www.sciencedaily.com/releases/2018/03/180307101033.htm
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
$2,382.00 Cellgenic Amniotic Fluid-Human placental Derived
https://www.adimarket.net/product/cellgenic-pure-pro-cord-blood-derived/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
CELLGENIC
http://cellgenic.com
https://www.adimarket.net/product/cellgenic-pure-cord-blood-derived/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
NASA and Techshot Trying To 3D Print Organs In Space
https://www.nasa.gov/mission_pages/station/research/news/spx18-research
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D Bioprinting Market To Reach USD 4.40 Billion
.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://www.linkedin.com/company/lans-holdings-inc
https://www.linkedin.com/in/dave-christensen-b38a82
http://www.lans.holdings
https://www.linkedin.com/company/tnt-blockchain
$1.37 per share..TNT Blockchain is led by President David Christensen
https://www.zkinternationalgroup.com/xsigma-corporation
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
Aesthetic Marketing Group Announces the First International Meeting on Marketing in Aesthetic Medicine
https://www.prunderground.com/aesthetic-marketing-group-announces-the-first-international-meeting-on-marketing-in-aesthetic-medicine/00124178/
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
LAB FACILITY AND EQUIPMENT
http://stemcellslab.net/facility-and-equipment/
JAPAN IN PROGRESS
http://stemcellslab.net/project-plan/
GSCG Provider Testimonials
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150433068
BUSINESS OPPORTUNITY
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
BENITO GLOBAL TRAVELS-PARTNERS FROM Kuwait TO CHILE
Medicel Stem Cell Laboratory Visit Santiago Chile
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile
http://adimarket.info/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
VidaCel Chile.
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Cell Culture Media $1.2B
8 Knee replacement?
9 ?
$LAHO GSCG..REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH. GOLDMAN SACH'S, BILLIONAIRES PURING MONEY INTO STEM CELLS. GSCG.. EACH DIVISION OF GSCG COULD RUN TO PENNIES..COMBINED?
QUOD ERAT DEMONSTRANDUM GLTA
$LAHO..Trillion-Dollar Longevity..BOFA, Goldman Conservative $600 Billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
The Trillion-Dollar Longevity Industry
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
https://www.inc.com/james-paine/3-industries-that-will-probably-create-the-first-trillionaire.html
https://www.nanalyze.com/2019/08/top-10-companies-longevity
US health..spending increased 5.8%..3.2 Trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Adimarket import.. 40 FOOT CONTAINER South Korea
Adimarker Llc imports from N-biotek, Inc. in South Korea through the port of Los Angeles, California
..DESCRIPTION CENTRIFUGES FOR LABORATORY USE 8421.19-1000
..SUPPLIER N-BIOTEK, INC.
https://www.importgenius.com/importers/adimarket-llc
Supplier N-Biotek $8.4M
Adimarket announce agreement.. N-Biotek to offer the Total Solution highly manipulated stem cell culture expansion lab, complete with equipment, training, facilities, stem cell processing center, clean rooms, project plan and more- a total turnkey lab solution for emerging stem cell businesses and industry professionals.
The announcement marks a new chapter in GSCG’s ongoing expansion, and commitment to bring stem cell therapies..
..Until now, Admarket has been GSCG’s online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals, offering basic tools and products to facilitate in-office stem cell procedures. However, through N-Biotek, Adimarket now offers the Total Solution labs and all the accoutrements. From planning to building the facility, to training and consultation, Total Solution users are equipped in every way possible to walk in and begin using their fully-equipped biotechnology lab in short order.
https://www.stemcelltraining.net/total-solution/
http://stemcellcenter.net/
N-Biotek History
http://www.n-biotek.com/index.php?module=Board&action=SiteBoard&iBrdNo=9&sMode=SELECT_FORM
Clinical trials news
http://www.mesenchymalcellnews.com/issue/volume-8-34-aug-30/
Product Catalog!
http://n-biotek.com/N-BIOTEK_PRODUCT_CATALOG_VOL_18.pdf
GSCG is #1 Competitor for Biostems Tech $1.52 Dark Defunct!
GCSG is #1 competitor for Beike Biotechnology.
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
GSCG is #1 competitor Global Institute Of Stem Cell Therapy And Research!
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
GSCG TREATING FORMER NFL PRO!
$LAHO Much appreciated, followed back.
Welcome to the Global Stem Cells Group website! GSCG is a group of companies, each dedicated to facilitating stem cell research and medicine.
Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
http://www.stemcellsgroup.com/our-story/
GSCG QATAR
GSCG Costa Rica
GSGC CHILE & ARGENTINA
GSGC MEXICO
SOUTH KOREA
https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473
https://twitter.com/StemCellGroupUS
GSCG Office $167k per year, Top Location!!!
$23.95 /SF/Yr
6,982 SF
A Class “A” office building
Demographics Salary $95k
https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
http://www.lans.holdings/
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Stem cells: THE FUTURE OF MEDICINE
Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp
$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
The Smart Money Is Piling Into Regenerative Medicine
Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine
The Goldman report discusses Samumed, a private RM company. With $300 million in funding, [b[color=red]]it’s valued at a staggering $12 billion[/color]. Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
$LAHO Venture-capital investors.. pouring money..regenerative medicine.
Goldman Sachs defines regenerative medicine as approaches that grow cells or tissue from stem cells, treatments that promote regeneration, or transplants using organs or tissue grown outside the body.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
Goldman Sachs highlighted..$12 billion private biotech startup that wants to regenerate hair, skin, bones, and joints, and Unity Biotechnology, which is working on treatments that act on senescent cells.
Money is pouring in to a hot new area of science that could change the way we think about aging
.."We believe companies backed by academic pioneers ... or those with novel platforms ... are likely to garner the largest investments and valuations," the report said.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
$LAHO Blankfein, Goldman Partners Hit Hamptons for Stem Cell Event
https://www.bloomberg.com/news/articles/2016-07-19/blankfein-goldman-partners-hit-hamptons-for-stem-cell-benefit
These are the students Goldman Sachs REALLY wants to hire
..37% of the analysts hired by Goldman Sachs last year were STEM majors according to Blankfein.
https://news.efinancialcareers.com/uk-en/273366/goldman-sachs-stem-students
https://www.goldmansachs.com/search/search.gscgi?query=STEM+CELLS
Cancer Biotech Firm Alpha Tau Medical Appoints Raphi Levy of Goldman Sachs as Chief Financial Officer
https://www.prnewswire.com/news-releases/cancer-biotech-firm-alpha-tau-medical-appoints-raphi-levy-of-goldman-sachs-as-chief-financial-officer-300818388.html
Lloyd Blankfein, the CEO of Goldman Sachs, announced on Tuesday that he has lymphoma..Stem cell transplantation could also be used as a treatment.
https://fortune.com/2015/09/22/lymphoma/
https://www.issca.us/
http://stemcellcenter.net/center/quito/
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
Stem cells are the clearest opportunity to provide humans with a potentially life-saving solution in the future..Furthermore, the combination of private and public healthcare is the subject of current research, as is the development of new solutions and therapies...
Today, stem cells..are routinely used to treat approximately 80 medical conditions including leukaemia, lymphoma, immune disorders and anaemia. However, affordability and accessibility remain a challenge.
https://www.europeanceo.com/business-and-management/how-stem-cell-treatments-can-make-medicine-effective-and-affordable/
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
Medical Tourism Market Worth $179.6 Billion By 2026 CAGR: 21.9%
https://www.grandviewresearch.com/press-release/global-medical-tourism-market
Stem cells: Creating a cure-all
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents say all this groundwork is finally coming to fruition, others call progress slow and plodding.
.."I would say the pace of things has been much faster than I would have predicted," says Andy McMahon, PhD, a W.M. Keck provost and university professor at the University of Southern California.
In comparison, Wells says, prescription drugs often take 15 years to progress from research stages to market.
https://www.webmd.com/brain/news/20190812/stem-cells-and-health-advances-where-are-we-now
US health..spending increased 5.8%..3.2 Trillion
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Cancer Reversion
Despite spending close to a trillion dollars in the “war on cancer” to date, the disease remains one of our major killers.
Organ Repair/Regeneration
Over $60 billion in care annually is spent on these patients, when only taking into account the costs of dialysis and kidney transplants
www.bioquark.com/bioquantine-programs/bq-a-clinical-plans/
At current rates, by 2025, nearly ¼ of the US GDP will be spent on healthcare.
It takes on average 12 years and $359 million to take a new drug from the lab to a patient.
Only 5 in 5,000 of these new drugs make it to human testing. From there, only 1 of those 5 is actually approved for human use.
And Now, the Good News:
We are in the midst of a (medical) revolution driven by exponential technology: artificial intelligence, sensors, robotics, 3D printing, big data, genomics and stem cells.
Today’s $3.8 trillion dollar healthcare industry is in the deceptive phase of its march towards dematerialization, demonetization and democratization (as I discuss in my A360 Summits).
Stem Cells:
We are now in the earliest stages of stem cell therapy development. Future therapies will be transformative and, frankly, mind-boggling.
Stem cell therapy promises tissue regeneration and renewal – and thus a “cure” for everything from blindness to spinal cord injuries, type 1 diabetes, Parkinson’s disease, Alzheimer’s disease, heart disease, stroke, burns, cancer and osteoarthritis.
In 2012, researchers at Cedars-Sinai reported one of the first cases of successful therapeutic stem cell treatment – they used patients’ own stem cells to regenerate heart tissue and undo damage from a heart attack.
https://www.diamandis.com/blog/life-or-death
$17.3 Bn Stem Cell Banking Market - Global Industry..CAGR of 13.5%
https://www.prnewswire.com/news-releases/17-3-bn-stem-cell-banking-market---global-industry-trends-share-size-growth-opportunity-and-forecast-2019-2024--300816982.html
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Knee replacement?
8 ?
9 ?
$LAHO GSCG ALL THESE BILLION DOLLAR SEGMENTS ADDING UP$$$$
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World
What Does Pfizer Have to do with the World of Stem Cells?
Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
CONSUMER REPORT..stem cells market. a whole lot of demand
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
The power to print money.
Trillions of dollars – on-demand.[/color]
..For the first time in history - central banks are now funneling trillions of dollars, directly into the stock market.
The Swiss National Bank is on a buying spree – adding hundreds of thousands of shares of Ford, Xcel Energy, Costco, and many other American companies to its portfolio in the last few months.
According to Bloomberg, The Bank of Japan is now the #1 buyer of Japanese stocks. And if their buying binge continues – within a few years, they could own the ENTIRE market!
China's Central bank – the world's largest central bank, worth more than $5.4 trillion -- is now a Top 10 shareholder in the biggest, most well-known stocks in Shanghai.
https://orders.thecrux.com/chain?cid=MKT376375&eid=MKT417624&step=start&assetId=AST90728&page=1
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150726448
Amag Pharma..buy world's largest stem..bank..$700 million
..and that it was on the hunt for more deals.
https://www.globenewswire.com/news-release/2015/06/29/748090/10139996/en/AMAG-Pharmaceuticals-to-Acquire-Cord-Blood-Registry.html
In 2018, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market..
https://www.globenewswire.com/news-release/2019/07/16/1883226/0/en/Global-Cell-Culture-Market-Outlook-Report-2019-2024-Pharmaceutical-Biotechnology-Companies-are-Expected-to-Dominate.html
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Harvard team grows cyborg mini-organs out of stem cells
https://newatlas.com/cyborg-organoids-mini-organs-sensors/61006/
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
Stem Cells Are Poised to Change Health and Medicine Forever
Transplanted cells offer middle-aged rodents an increased life span
https://www.scientificamerican.com/article/brains-stem-cells-slow-aging-in-mice/
Bone Marrow Transplants Increase Healthy Lifespan in Mice
Stem Cell Start-up Could Extend Lifespan by Decades
Will 100 be the new 60?
https://wallstreetpit.com/114544-stem-cell-extend-lifespan-decades/
..The new biotech initiative whose board includes former Apple CEO John Sculley, ex-FDA commissioner Andrew Von Eschenbach and founder of Alphabet’s venture capital arm Bill Maris, is built around the idea that stem cells found in postpartum human placentas are ideal for regenerating damaged and aged tissue
https://wallstreetpit.com/114544-stem-cell-extend-lifespan-decades/
https://www.google.com/amp/s/singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/amp/
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Johns Hopkins
The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done
https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-
with-stem-cells
For a limited time promotional shipping rates are available on most orders over $ 5000 .
https://www.adimarket.net/how-to-order/
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Hair Transplant Market worth over $24.8 billion by 2024:
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
$LAHO..US health..spending increased 5.8% to..USD 3.2 Trillion trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Who Wants To Live Forever?..The Super-Rich, That's Who (And Most Everyone Else)
..Not only do many of the super-rich want immortality, but a good number of them are doing something about it. The likes of Sergey Brin, co-founder of Google, Larry Ellison, Co-founder of Oracle, and investor Peter Thiel are all putting money into ventures that are focused on extending the human life span.
..Hacking our DNA is another approach being taken. Our ability to use stem cells to cure disease is becoming increasingly an opportunity. Very possibly using stem cell technology, as well as modifications to our DNA, can result in significantly longer fruitful lives.
https://www.forbes.com/sites/russalanprince/2018/01/02/who-wants-to-live-forever-the-super-rich-thats-who-and-most-everyone-else/amp/
Anti-aging and the billionaires young blood & stem cell club
https://ipscell.com/2018/09/anti-aging-and-the-billionaires-young-blood-stem-cell-club/
https://www.nextbigfuture.com/2018/08/80-year-old-billionaires-are-injecting-placental-stem-cells-to-boost-lifespan-and-health.html?amp
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
Venture capital investments..record.. $207 billion
https://singularityhub.com/2019/08/20/these-are-the-meta-trends-shaping-the-future-at-breakneck-speed/
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Stem Cells Lead To A Genuine Miracle Cure
Exosomes, metastases, and the miracle of cancer stem cell markers
https://www.ncbi.nlm.nih.gov/pubmed/31030373
Stem Cell Treatment Could Be a Game-Changer for People With MS
https://time.com/5205946/stem-cell-treatment-multiple-sclerosis-patients/
On the immortality of stem cells
University of Cologne
Summary: Stem cells are considered to be immortal in culture and, therefore, of great interest for aging research. This immortality is regulated by increased proteostasis, which controls the quality of proteins. A team of researchers found a link between increased proteostasis and immortality of human embryonic stem cells
https://www.sciencedaily.com/releases/2018/03/180307101033.htm
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
$2,382.00 Cellgenic Amniotic Fluid-Human placental Derived
https://www.adimarket.net/product/cellgenic-pure-pro-cord-blood-derived/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
CELLGENIC
http://cellgenic.com
https://www.adimarket.net/product/cellgenic-pure-cord-blood-derived/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
NASA and Techshot Trying To 3D Print Organs In Space
https://www.nasa.gov/mission_pages/station/research/news/spx18-research
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D Bioprinting Market To Reach USD 4.40 Billion
.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://www.linkedin.com/company/lans-holdings-inc
https://www.linkedin.com/in/dave-christensen-b38a82
http://www.lans.holdings
https://www.linkedin.com/company/tnt-blockchain
$1.37 per share..TNT Blockchain is led by President David Christensen
https://www.zkinternationalgroup.com/xsigma-corporation
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
Aesthetic Marketing Group Announces the First International Meeting on Marketing in Aesthetic Medicine
https://www.prunderground.com/aesthetic-marketing-group-announces-the-first-international-meeting-on-marketing-in-aesthetic-medicine/00124178/
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
LAB FACILITY AND EQUIPMENT
http://stemcellslab.net/facility-and-equipment/
JAPAN IN PROGRESS
http://stemcellslab.net/project-plan/
GSCG Provider Testimonials
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150433068
BUSINESS OPPORTUNITY
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
BENITO GLOBAL TRAVELS-PARTNERS FROM Kuwait TO CHILE
Medicel Stem Cell Laboratory Visit Santiago Chile
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile
http://adimarket.info/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
VidaCel Chile.
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Cell Culture Media $1.2B
8 Knee replacement?
9 ?
$LAHO GSCG..REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH. GOLDMAN SACH'S, BILLIONAIRES PURING MONEY INTO STEM CELLS. GSCG.. EACH DIVISION OF GSCG COULD RUN TO PENNIES..COMBINED?
QUOD ERAT DEMONSTRANDUM GLTA
$LAHO Stem Cells Paralysis cure, and cure for incurable’s..
Kusachi recalled of the incident that damaged his spinal cord and left him mostly paralyzed.
..Kusachi soon joined a clinical trial for a new treatment for spinal cord injuries called Stemirac. Researchers at Sapporo Medical University drew fluid from his bone marrow, isolated a type of stem cell found there, multiplied the cells in the lab, and infused them back into his bloodstream intravenously. The day after the treatment, Kusachi dramatically improved. “That was a real surprise to us,” said Toshihiko Yamashita, an orthopedic surgeon at the university. “In the afternoon, he could rise up from his bed and sit. In the evening, he was getting around in a wheelchair.”
The improvement continued. Seven months after the injection, Kusachi left the hospital under his own power. Today, although control of his hands and feet is still clumsy, he cooks, drives, and teaches math online — all thanks, he says, to Stemirac.
The Japanese health ministry approved Stemirac last December, and the treatment is now available to the Japanese public,
https://undark.org/article/new-japanese-stem-cell-treatment-debate/
Brings leadership in stem cell research, patient applications, and training to you through our state-of-the-art global network of companies. Our mission is to enable physicians to make the benefits of stem cell medicine a reality for patients around the world.
http://www.stemcellsgroup.com/
Pioneering Stem Cell Trial Seeks to Cure Babies Before Birth
..The disease, which has no cure, is usually fatal for a developing fetus.
But while still in her mother’s womb, Elianna received a highly daring treatment. Doctors isolated healthy blood stem cells from her mother and injected them through a blood vessel that runs down the umbilical cord. Four months later, Elianna was born with a loud cry and a glistening head of hair, defying all medical odds.
https://singularityhub.com/2018/06/13/pioneering-stem-cell-trial-seeks-to-cure-babies-before-birth/amp/
Chasing a Cure for Lung Disease With Stem Cells: A Conversation With Finn Hawkins
You can take a cell from your skin, explained Darrell Kotton, MD, grow it in a dish, and then reprogram it to make a stem cell capable of becoming any cell type in the body. If you could succeed in turning those stem cells into functioning lung cells, Kotton went on, it could resolve a major bottleneck in pulmonology research — limited access to tissue samples — and accelerate a cure for cystic fibrosis and other diseases
https://www.bmc.org/healthcity/research/chasing-cure-lung-disease-stem-cells
GLOBAL STEM CELLS GROUP AND WESTMINSTER UNIVERSITY IN KOREA AWARD CERTIFICATES
..Dr. Paul In Chan Chung personally handed each student his or her certificate.
“This was a monumental recognition ceremony for students who have gone above and beyond with regards our regenerative medicine lab-setting course,” said Novas. “We need more people to be committed to furthering the effects of stem cell medicine, and this batch of students is well on their way to contributing to the future of the industry.”
https://www.stemcelltraining.net/global-stem-cells-group-and-westminster-university-in-korea-award-certificates/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150827110
Every year about 600,000 Americans get a knee replacement, a number that could rise to 3 million by 2030. Until recently, treatment options were either temporary or surgical.
Now, in numerous cases, stem cell therapy for knees is reducing pain and repairing cartilage. As a result, many people have been able to improve their quality of life and avoid surgery.
Side effects
Stem cell treatment for knees is noninvasive and rarely painful. Side effects are minimal.
https://www.healthline.com/health/stem-cell-therapy-for-knees#treatment
Stem cells: Creating a cure-all
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Stem Cells and Health Advances: Where Are We Now?
..It worked. Kuehl sees better
Stem Cells: 30 Years and Counting
Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents say all this groundwork is finally coming to fruition, others call progress slow and plodding.
.."I would say the pace of things has been much faster than I would have predicted," says Andy McMahon, PhD, a W.M. Keck provost and university professor at the University of Southern California.
In comparison, Wells says, prescription drugs often take 15 years to progress from research stages to market.
https://www.webmd.com/brain/news/20190812/stem-cells-and-health-advances-where-are-we-now
GSCG PATENTS AND CERTIFICATIONS & Awards
Our Company has been certified by Independent and international reviewers, we have achieved the highest possible standard and quality of services
STEM CELL TECHNOLOGY
PATENT 2 STEM CELL MASS PRODUCTION
PATENT 3 STEM CELL CULTURE MEDIA
http://stemcellslab.net/about/patents-and-certifications/
Several billionaires, most of them Californians, have been funding firms involved in developing life-extension technologies. What if they succeed? What if billionaires alive today live indefinitely and get ever richer?
Some of the more recognizable names who have been putting money into such efforts: Larry Ellison (founder of Oracle), Larry Page and Sergey Brin (founders of Google), Jeff Bezos (founder of Amazon), and Peter Thiel, cofounder of PayPal and Palantir Technologies.
https://www.dw.com/en/what-if-billionaires-could-live-forever/a-42840013
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150850741
Harvard* Any Patient With Any Disease
https://hsci.harvard.edu/news/any-patient-any-disease
https://www.businessinsider.com/why-abbvie-acquired-stemcentrx-2016-4
Cell Culture Media Market
The global cell culture media market can now envision a leap from USD 703.1 million to USD 1290.1 million during the forecast period (2017-2023).
https://www.marketwatch.com/press-release/cell-culture-media-market-2018-assessment-industry-forecast-highlighting-growth-trends-up-to-2023-2018-10-11
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Cell Culture Media $1.2B
8 Knee replacement?
9 ?
$LAHO GSCG FUTURE OF MEDICINE, EACH DIVISION WORTH PENNIES..COMBINED!!$$$
$LAHO..Trillion-Dollar Longevity Industry..Goldman Conservative $600 Billion..BOFA,
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
The Trillion-Dollar Longevity Industry
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
https://www.inc.com/james-paine/3-industries-that-will-probably-create-the-first-trillionaire.html
https://www.nanalyze.com/2019/08/top-10-companies-longevity
US health..spending increased 5.8%..3.2 Trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Adimarket import.. 40 FOOT CONTAINER South Korea
Adimarker Llc imports from N-biotek, Inc. in South Korea through the port of Los Angeles, California
..DESCRIPTION CENTRIFUGES FOR LABORATORY USE 8421.19-1000
..SUPPLIER N-BIOTEK, INC.
https://www.importgenius.com/importers/adimarket-llc
Supplier N-Biotek $8.4M
Adimarket announce agreement.. N-Biotek to offer the Total Solution highly manipulated stem cell culture expansion lab, complete with equipment, training, facilities, stem cell processing center, clean rooms, project plan and more- a total turnkey lab solution for emerging stem cell businesses and industry professionals.
The announcement marks a new chapter in GSCG’s ongoing expansion, and commitment to bring stem cell therapies..
..Until now, Admarket has been GSCG’s online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals, offering basic tools and products to facilitate in-office stem cell procedures. However, through N-Biotek, Adimarket now offers the Total Solution labs and all the accoutrements. From planning to building the facility, to training and consultation, Total Solution users are equipped in every way possible to walk in and begin using their fully-equipped biotechnology lab in short order.
https://www.stemcelltraining.net/total-solution/
http://stemcellcenter.net/
N-Biotek History
http://www.n-biotek.com/index.php?module=Board&action=SiteBoard&iBrdNo=9&sMode=SELECT_FORM
Clinical trials news
http://www.mesenchymalcellnews.com/issue/volume-8-34-aug-30/
Product Catalog!
http://n-biotek.com/N-BIOTEK_PRODUCT_CATALOG_VOL_18.pdf
GSCG is #1 Competitor for Biostems Tech $1.52 Dark Defunct!
GCSG is #1 competitor for Beike Biotechnology.
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
GSCG is #1 competitor Global Institute Of Stem Cell Therapy And Research!
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
GSCG TREATING FORMER NFL PRO!
$LAHO Much appreciated, followed back.
Welcome to the Global Stem Cells Group website! GSCG is a group of companies, each dedicated to facilitating stem cell research and medicine.
Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
http://www.stemcellsgroup.com/our-story/
GSCG QATAR
GSCG Costa Rica
GSGC CHILE & ARGENTINA
GSGC MEXICO
SOUTH KOREA
https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473
https://twitter.com/StemCellGroupUS
GSCG Office $167k per year, Top Location!!!
$23.95 /SF/Yr
6,982 SF
A Class “A” office building
Demographics Salary $95k
https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
http://www.lans.holdings/
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Stem cells: THE FUTURE OF MEDICINE
Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp
$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
The Smart Money Is Piling Into Regenerative Medicine
Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine
The Goldman report discusses Samumed, a private RM company. With $300 million in funding, [b[color=red]]it’s valued at a staggering $12 billion[/color]. Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
$LAHO Venture-capital investors.. pouring money..regenerative medicine.
Goldman Sachs defines regenerative medicine as approaches that grow cells or tissue from stem cells, treatments that promote regeneration, or transplants using organs or tissue grown outside the body.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
Goldman Sachs highlighted..$12 billion private biotech startup that wants to regenerate hair, skin, bones, and joints, and Unity Biotechnology, which is working on treatments that act on senescent cells.
Money is pouring in to a hot new area of science that could change the way we think about aging
.."We believe companies backed by academic pioneers ... or those with novel platforms ... are likely to garner the largest investments and valuations," the report said.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
$LAHO Blankfein, Goldman Partners Hit Hamptons for Stem Cell Event
https://www.bloomberg.com/news/articles/2016-07-19/blankfein-goldman-partners-hit-hamptons-for-stem-cell-benefit
These are the students Goldman Sachs REALLY wants to hire
..37% of the analysts hired by Goldman Sachs last year were STEM majors according to Blankfein.
https://news.efinancialcareers.com/uk-en/273366/goldman-sachs-stem-students
https://www.goldmansachs.com/search/search.gscgi?query=STEM+CELLS
Cancer Biotech Firm Alpha Tau Medical Appoints Raphi Levy of Goldman Sachs as Chief Financial Officer
https://www.prnewswire.com/news-releases/cancer-biotech-firm-alpha-tau-medical-appoints-raphi-levy-of-goldman-sachs-as-chief-financial-officer-300818388.html
Lloyd Blankfein, the CEO of Goldman Sachs, announced on Tuesday that he has lymphoma..Stem cell transplantation could also be used as a treatment.
https://fortune.com/2015/09/22/lymphoma/
https://www.issca.us/
http://stemcellcenter.net/center/quito/
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
Stem cells are the clearest opportunity to provide humans with a potentially life-saving solution in the future..Furthermore, the combination of private and public healthcare is the subject of current research, as is the development of new solutions and therapies...
Today, stem cells..are routinely used to treat approximately 80 medical conditions including leukaemia, lymphoma, immune disorders and anaemia. However, affordability and accessibility remain a challenge.
https://www.europeanceo.com/business-and-management/how-stem-cell-treatments-can-make-medicine-effective-and-affordable/
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
Medical Tourism Market Worth $179.6 Billion By 2026 CAGR: 21.9%
https://www.grandviewresearch.com/press-release/global-medical-tourism-market
Stem cells: Creating a cure-all
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents say all this groundwork is finally coming to fruition, others call progress slow and plodding.
.."I would say the pace of things has been much faster than I would have predicted," says Andy McMahon, PhD, a W.M. Keck provost and university professor at the University of Southern California.
In comparison, Wells says, prescription drugs often take 15 years to progress from research stages to market.
https://www.webmd.com/brain/news/20190812/stem-cells-and-health-advances-where-are-we-now
US health..spending increased 5.8%..3.2 Trillion
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Cancer Reversion
Despite spending close to a trillion dollars in the “war on cancer” to date, the disease remains one of our major killers.
Organ Repair/Regeneration
Over $60 billion in care annually is spent on these patients, when only taking into account the costs of dialysis and kidney transplants
www.bioquark.com/bioquantine-programs/bq-a-clinical-plans/
At current rates, by 2025, nearly ¼ of the US GDP will be spent on healthcare.
It takes on average 12 years and $359 million to take a new drug from the lab to a patient.
Only 5 in 5,000 of these new drugs make it to human testing. From there, only 1 of those 5 is actually approved for human use.
And Now, the Good News:
We are in the midst of a (medical) revolution driven by exponential technology: artificial intelligence, sensors, robotics, 3D printing, big data, genomics and stem cells.
Today’s $3.8 trillion dollar healthcare industry is in the deceptive phase of its march towards dematerialization, demonetization and democratization (as I discuss in my A360 Summits).
Stem Cells:
We are now in the earliest stages of stem cell therapy development. Future therapies will be transformative and, frankly, mind-boggling.
Stem cell therapy promises tissue regeneration and renewal – and thus a “cure” for everything from blindness to spinal cord injuries, type 1 diabetes, Parkinson’s disease, Alzheimer’s disease, heart disease, stroke, burns, cancer and osteoarthritis.
In 2012, researchers at Cedars-Sinai reported one of the first cases of successful therapeutic stem cell treatment – they used patients’ own stem cells to regenerate heart tissue and undo damage from a heart attack.
https://www.diamandis.com/blog/life-or-death
$17.3 Bn Stem Cell Banking Market - Global Industry..CAGR of 13.5%
https://www.prnewswire.com/news-releases/17-3-bn-stem-cell-banking-market---global-industry-trends-share-size-growth-opportunity-and-forecast-2019-2024--300816982.html
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Knee replacement?
8 ?
9 ?
$LAHO GSCG ALL THESE BILLION DOLLAR SEGMENTS ADDING UP$$$$
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World
What Does Pfizer Have to do with the World of Stem Cells?
Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
CONSUMER REPORT..stem cells market. a whole lot of demand
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
The power to print money.
Trillions of dollars – on-demand.[/color]
..For the first time in history - central banks are now funneling trillions of dollars, directly into the stock market.
The Swiss National Bank is on a buying spree – adding hundreds of thousands of shares of Ford, Xcel Energy, Costco, and many other American companies to its portfolio in the last few months.
According to Bloomberg, The Bank of Japan is now the #1 buyer of Japanese stocks. And if their buying binge continues – within a few years, they could own the ENTIRE market!
China's Central bank – the world's largest central bank, worth more than $5.4 trillion -- is now a Top 10 shareholder in the biggest, most well-known stocks in Shanghai.
https://orders.thecrux.com/chain?cid=MKT376375&eid=MKT417624&step=start&assetId=AST90728&page=1
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150726448
Amag Pharma..buy world's largest stem..bank..$700 million
..and that it was on the hunt for more deals.
https://www.globenewswire.com/news-release/2015/06/29/748090/10139996/en/AMAG-Pharmaceuticals-to-Acquire-Cord-Blood-Registry.html
In 2018, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market..
https://www.globenewswire.com/news-release/2019/07/16/1883226/0/en/Global-Cell-Culture-Market-Outlook-Report-2019-2024-Pharmaceutical-Biotechnology-Companies-are-Expected-to-Dominate.html
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Harvard team grows cyborg mini-organs out of stem cells
https://newatlas.com/cyborg-organoids-mini-organs-sensors/61006/
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
Stem Cells Are Poised to Change Health and Medicine Forever
Transplanted cells offer middle-aged rodents an increased life span
https://www.scientificamerican.com/article/brains-stem-cells-slow-aging-in-mice/
Bone Marrow Transplants Increase Healthy Lifespan in Mice
Stem Cell Start-up Could Extend Lifespan by Decades
Will 100 be the new 60?
https://wallstreetpit.com/114544-stem-cell-extend-lifespan-decades/
..The new biotech initiative whose board includes former Apple CEO John Sculley, ex-FDA commissioner Andrew Von Eschenbach and founder of Alphabet’s venture capital arm Bill Maris, is built around the idea that stem cells found in postpartum human placentas are ideal for regenerating damaged and aged tissue
https://wallstreetpit.com/114544-stem-cell-extend-lifespan-decades/
https://www.google.com/amp/s/singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/amp/
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Johns Hopkins
The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done
https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-
with-stem-cells
For a limited time promotional shipping rates are available on most orders over $ 5000 .
https://www.adimarket.net/how-to-order/
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Hair Transplant Market worth over $24.8 billion by 2024:
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
$LAHO..US health..spending increased 5.8% to..USD 3.2 Trillion trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Who Wants To Live Forever?..The Super-Rich, That's Who (And Most Everyone Else)
..Not only do many of the super-rich want immortality, but a good number of them are doing something about it. The likes of Sergey Brin, co-founder of Google, Larry Ellison, Co-founder of Oracle, and investor Peter Thiel are all putting money into ventures that are focused on extending the human life span.
..Hacking our DNA is another approach being taken. Our ability to use stem cells to cure disease is becoming increasingly an opportunity. Very possibly using stem cell technology, as well as modifications to our DNA, can result in significantly longer fruitful lives.
https://www.forbes.com/sites/russalanprince/2018/01/02/who-wants-to-live-forever-the-super-rich-thats-who-and-most-everyone-else/amp/
Anti-aging and the billionaires young blood & stem cell club
https://ipscell.com/2018/09/anti-aging-and-the-billionaires-young-blood-stem-cell-club/
https://www.nextbigfuture.com/2018/08/80-year-old-billionaires-are-injecting-placental-stem-cells-to-boost-lifespan-and-health.html?amp
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
Venture capital investments..record.. $207 billion
https://singularityhub.com/2019/08/20/these-are-the-meta-trends-shaping-the-future-at-breakneck-speed/
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Stem Cells Lead To A Genuine Miracle Cure
Exosomes, metastases, and the miracle of cancer stem cell markers
https://www.ncbi.nlm.nih.gov/pubmed/31030373
Stem Cell Treatment Could Be a Game-Changer for People With MS
https://time.com/5205946/stem-cell-treatment-multiple-sclerosis-patients/
On the immortality of stem cells
University of Cologne
Summary: Stem cells are considered to be immortal in culture and, therefore, of great interest for aging research. This immortality is regulated by increased proteostasis, which controls the quality of proteins. A team of researchers found a link between increased proteostasis and immortality of human embryonic stem cells
https://www.sciencedaily.com/releases/2018/03/180307101033.htm
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
$2,382.00 Cellgenic Amniotic Fluid-Human placental Derived
https://www.adimarket.net/product/cellgenic-pure-pro-cord-blood-derived/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
CELLGENIC
http://cellgenic.com
https://www.adimarket.net/product/cellgenic-pure-cord-blood-derived/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
NASA and Techshot Trying To 3D Print Organs In Space
https://www.nasa.gov/mission_pages/station/research/news/spx18-research
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D Bioprinting Market To Reach USD 4.40 Billion
.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://www.linkedin.com/company/lans-holdings-inc
https://www.linkedin.com/in/dave-christensen-b38a82
http://www.lans.holdings
https://www.linkedin.com/company/tnt-blockchain
$1.37 per share..TNT Blockchain is led by President David Christensen
https://www.zkinternationalgroup.com/xsigma-corporation
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
Aesthetic Marketing Group Announces the First International Meeting on Marketing in Aesthetic Medicine
https://www.prunderground.com/aesthetic-marketing-group-announces-the-first-international-meeting-on-marketing-in-aesthetic-medicine/00124178/
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
LAB FACILITY AND EQUIPMENT
http://stemcellslab.net/facility-and-equipment/
JAPAN IN PROGRESS
http://stemcellslab.net/project-plan/
GSCG Provider Testimonials
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150433068
BUSINESS OPPORTUNITY
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
BENITO GLOBAL TRAVELS-PARTNERS FROM Kuwait TO CHILE
Medicel Stem Cell Laboratory Visit Santiago Chile
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile
http://adimarket.info/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
VidaCel Chile.
$LAHO GSCG..REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH. GOLDMAN SACH'S, BILLIONAIRES PURING MONEY INTO STEM CELLS..TRILLION DOLLAR LONGEVITY-THERAPY MARKET.. EACH SEGMENT WORTH BILLIONS, EACH DIVISION OF GSCG COULD RUN TO PENNIES..COMBINED?
QUOD ERAT DEMONSTRANDUM GLTA
$LAHO ..Stem cells are the clearest opportunity to provide humans with a potentially life-saving solution in the future..Furthermore, the combination of private and public healthcare is the subject of current research, as is the development of new solutions and therapies...
Today, stem cells..are routinely used to treat approximately 80 medical conditions including leukaemia, lymphoma, immune disorders and anaemia. However, affordability and accessibility remain a challenge.
https://www.europeanceo.com/business-and-management/how-stem-cell-treatments-can-make-medicine-effective-and-affordable/
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
Medical Tourism Market Worth $179.6 Billion By 2026 CAGR: 21.9%
https://www.grandviewresearch.com/press-release/global-medical-tourism-market
Stem cells: Creating a cure-all
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents say all this groundwork is finally coming to fruition, others call progress slow and plodding.
.."I would say the pace of things has been much faster than I would have predicted," says Andy McMahon, PhD, a W.M. Keck provost and university professor at the University of Southern California.
In comparison, Wells says, prescription drugs often take 15 years to progress from research stages to market.
https://www.webmd.com/brain/news/20190812/stem-cells-and-health-advances-where-are-we-now
US health..spending increased 5.8%..3.2 Trillion
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Cancer Reversion
Despite spending close to a trillion dollars in the “war on cancer” to date, the disease remains one of our major killers.
Organ Repair/Regeneration
Over $60 billion in care annually is spent on these patients, when only taking into account the costs of dialysis and kidney transplants
www.bioquark.com/bioquantine-programs/bq-a-clinical-plans/
At current rates, by 2025, nearly ¼ of the US GDP will be spent on healthcare.
It takes on average 12 years and $359 million to take a new drug from the lab to a patient.
Only 5 in 5,000 of these new drugs make it to human testing. From there, only 1 of those 5 is actually approved for human use.
And Now, the Good News:
We are in the midst of a (medical) revolution driven by exponential technology: artificial intelligence, sensors, robotics, 3D printing, big data, genomics and stem cells.
Today’s $3.8 trillion dollar healthcare industry is in the deceptive phase of its march towards dematerialization, demonetization and democratization (as I discuss in my A360 Summits).
Stem Cells:
We are now in the earliest stages of stem cell therapy development. Future therapies will be transformative and, frankly, mind-boggling.
Stem cell therapy promises tissue regeneration and renewal – and thus a “cure” for everything from blindness to spinal cord injuries, type 1 diabetes, Parkinson’s disease, Alzheimer’s disease, heart disease, stroke, burns, cancer and osteoarthritis.
In 2012, researchers at Cedars-Sinai reported one of the first cases of successful therapeutic stem cell treatment – they used patients’ own stem cells to regenerate heart tissue and undo damage from a heart attack.
https://www.diamandis.com/blog/life-or-death
$17.3 Bn Stem Cell Banking Market - Global Industry..CAGR of 13.5%
https://www.prnewswire.com/news-releases/17-3-bn-stem-cell-banking-market---global-industry-trends-share-size-growth-opportunity-and-forecast-2019-2024--300816982.html
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Knee replacement?
8 ?
9 ?
$LAHO GSCG ALL THESE BILLION DOLLAR SEGMENTS ADDING UP$$$$
$LAHO Great find, advancements every week, studies indicate Stem cells therapy extends life for 3 years. Pet market"$72-billion-a-year market pretty big. 3D printer market was $4B, lets have a look at another sector.
Hair Transplant Market..to exceed USD 24.8 billion by 2024
https://www.marketwatch.com/press-release/hair-transplant-market-outlook-with-industry-review-and-forecasts-2019-04-02
Organ Repair/Regeneration
Over $60 billion in care annually is spent on these patients
http://www.bioquark.com/bioquantine-programs/bq-a-clinical-plans/
..GSCG affiliate Adimarket announces the launch of the Cellgenic adipose-derived stem cell hair restoration application that maximizes the skin and hair follicles’ own revitalizing capabilities.
https://www.stemcelltraining.net/tag/stem-cells/page/2/
http://www.stemcellsgroup.com/prp-stem-cell-treatments-studied-hair-loss/hair-loss/
GSCG has signed an agreement with Dra. Caicedo, a specialist in hair loss treatment with an interest in delivering stem cell based treatments to her patients in Valencia.
https://www.globenewswire.com/news-release/2019/06/12/1867610/0/en/LAHO-Global-Stem-Cells-Group-Announces-Opening-of-Two-New-Stem-Cell-Centers.html
Immortality by 2030?
In late February, Diamandis wrote to subscribers of his email bulletin: "I asked the smartest people I know for their tech predictions for the next 20 years (2018 – 2038). What are the breakthroughs we can expect on our countdown to the Singularity?"
One of the predictions he listed was that by 2030, "humanity will have achieved Longevity Escape Velocity for the wealthiest."
https://www.dw.com/en/what-if-billionaires-could-live-forever/a-42840013
$LAHO GSCG each sector worth Billions let’s take a look at one$$
3D Bioprinting Market To Reach USD 4.40 Billion
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
New bioprinting tech creates body parts within seconds
..The process involves projecting a laser beam down into a slowly-spinning tube that's filled with a stem cell-laden photosensitive hydrogel. By selectively focusing the light energy at specific locations within the tube, it's possible to solidify the gel in those places only, building up the desired three-dimensional object within a matter of seconds. The stem cells are unharmed in the process.
https://newatlas.com/3d-printing/volumetric-3d-bioprinting/
The International Space Station Has a New Partner in Regenerative Medicine
..orbiting laboratory and scientists continue to experiment with 3D printing in space.
..Scientists will look to exploit the unique behavior of stem cells in microgravity to improve cell-based therapies for a variety of diseases and impairments, including traumatic brain injury and type I diabetes.
https://3dprint.com/252388/the-international-space-station-has-a-new-partner-in-regenerative-medicine/
NASA and Techshot Trying To 3D Print Organs In Space
https://www.nasa.gov/mission_pages/station/research/news/spx18-research/
..“Our objective is to bring this cutting-edge 3D bioprinting technology to scientists and regenerative medicine researcher throughout Lain America,” says Global Stem Cells Group founder and CEO Benito Novas. “CELLINK has revolutionized tissue engineering with its range of bioprinters, and we’re excited to make this process available to scientists and regenerative medicine researchers in Mexico, Central America, and South America.
https://www.stemcellscourse.com/global-stem-cells-group-to-represent-cellink-3d-bioprinting-technology-in-latin-america/
Global Stem Cells Group to Represent CELLINK 3D Bioprinting Technology in Latin America
http://www.stemcellsgroup.com/tag/stem-cell-research/
INKREDIBLE 3D BIOPRINTER ADIMAKET
https://www.adimarket.net/product-category/cellular-and-tissue-based-products/
$LAHO GSCG The future of Medicine, each sector worth Billions, printers, cosmetic, therapy, marketing, tourism, medical devices. Billions of dollars from big pharm will find the route to regenerative care. Best to measure against the market as seen fit$$$
$LAHO Anytime my friend GSCG future of Medicine$$
..Groundbreaking stem cell research could treat deadly diseases
., What if liposuction could undo the damage caused by degenerative conditions? What sounds too good to be true may be a new breakthrough in medicine, thanks to research taking place on the UF Health Jacksonville campus.
Adipose tissue, or fat, contains 500 to 1,000 times more stem cells than other commonly known sources, such as cord blood or bone marrow.
https://hscj.ufl.edu/news/story.aspx?id=1992
Global Stem Cells Group Takes Part in Clinical Trial.
..participation in a clinical trial designed to explore the safety and improvement of treatment protocols using adipose-derived stem cells.
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
https://clinicaltrials.gov/ct2/show/NCT03752827.
NASA..Space Tissue Loss - Stem Cell Regeneration
https://www.nasa.gov/mission_pages/station/research/experiments/explorer/Investigation.html?#id=791
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
Venture capital investments..record.. $207 billion
https://singularityhub.com/2019/08/20/these-are-the-meta-trends-shaping-the-future-at-breakneck-speed/
GSCG partner Magellan $7B.. acquires++
adult stem cell technology Arteriocyte Medical Systems Inc., created by Arteriocyte Inc. and DW Healthcare Partners, acquires Magellan Platelet Gel Business
http://blog.case.edu/case-news/2007/11/08/magellan
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
..headquartered in Hopkinton, Mass., the Magellan Autologous Platelet Separator is a high-tech, automated dual spin processing system designed for use in clinical laboratories or intraoperatively at the point-of-care for safe and rapid preparation of high-quality, platelet-rich plasma (PRP) as well as platelet poor plasma (PPP).
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
https://www.stemcellsgroup.com/category/press-releases/page/7/
Autologous Platelet Gel Applications During Cardiovascular Surgery: Effect on Wound Healing
CONCLUSIONS
In this pilot study, we found support that chest and leg pain were decreased in the experimental group, and we observed that the experimental group had less bruising
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682529/
https://www.istobiologics.com/resources/magellan-ifu
PRP AND STEM CELL TREATMENTS BEING STUDIED FOR HAIR LOSS
Adimarket helps, alongside a few other companies, to help provide new and reliable uses for PRP and stem cell therapies. We provide the equipment and other services so that doctors and practices will be able to provide these services to their patients.
..These include doctors, and practices, such as a doctor from Miami known as Lazaro M Garcia Md. This doctor already utilized PRP and stem cell therapy for people who suffer from hair loss, and is currently conducting a study that is supported by the National Institutes of Health.
http://www.stemcellsgroup.com/prp-stem-cell-treatments-studied-hair-loss/
Hair., Market..expand..25% CAGR..USD 24.8 bn by 2024
https://www.reuters.com/brandfeatures/venture-capital/article?id=69816%C2%A0
Stem Cell Training has been the Alma Mater in Regenerative Medicine and Cellular Therapies to close to 3000 physicians worldwide.
https://www.stemcelltraining.net/
$LAHO GSCG Each division worth, pennies, each sector worth Billions..Combined??$$
$LAHO GSCG.. Authorized Distributor of GMTN Exosome Injection and Other Biological Products..
Scientists believe that stem cell research can be used to treat medical conditions including Parkinson's disease, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis and rheumatoid arthritis.
http://www.stemcellsgroup.com/global-stem-cells-group-named-authorized-distributor-of-gmtn-exosome-injection-and-other-biological-products/
GSCG Advisory Board Ming Zhang Jie, MD
http://www.stemcellsgroup.com/advisory-board/
Stay tuned to our upcoming certifications!
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
Adimarket, LLC Looks to Expand Market Reach with Launch of New PRP Product
..“Adimarket and its products have been met with great enthusiasm from physicians in the US and Latin America,” said Benito Novas, CEO of the Global Stem Cells Group
http://www.stemcellsgroup.com/adimarket-llc-looks-to-expand-market-reach-with-launch-of-new-prp-product/
Rejuvenating brain stem cells may hold key to future MS treatments
https://www.medicalnewstoday.com/articles/amp/326066
Stem cells: the future of medicine
Future of Stem Cell Therapeutics
Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp
Forbes..Regenerative Medicine..Healthcare's Saving Grace?
Regenerative Medicine: Could This Be Healthcare's Saving Grace?
..Knee Replacements will be Unnecessary in the Next Five Years Cell therapy makes up over 60% of the regenerative medicine market, most of which is in the area of stem cell therapy. Adult stem cells can be used in the areas of cardiology; musculo-skeletal, including neurology; optometry; dermatology; cosmology; wound healing; and cancer. Stem cell therapy, when combined with immune and gene therapy, shows even greater potential to cure diseases.
..These international clinics are charging anywhere from $20,000 to $100,000 per treatment, and they are not covered by insurance.
https://www.forbes.com/sites/reenitadas/2015/11/06/regenerative-medicine-could-this-be-healthcares-saving-grace/#7d9e655c1049
$LAHO Future of Medicine industry embracing$$$
$LAHO GSCG Any patient any cure$$$
UCLA What can stem cells do?
Stem cells have the potential to: • Replace cell tissue that has been damaged or destroyed by illness, • Replicate themselves over and over for a very long time, • Help scientists understand the origin of human biological development • Help scientists understand healthy & diseased cells in hope of creating treatments & cures for many diseases.
The National Institutes for Health (NIH) notes that stem cells “have the remarkable potential to develop into many different cell types in the body. Serving as a sort of repair system for the body, they can theoretically divide without limit to replenish other cells for as long as the person or animal is still alive. When a stem cell divides, each ‘daughter’ cell has the potential to either remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell. A more detailed primer on stem cells can be found at stemcells.nih.gov/info/basics.”
https://stemcell.ucla.edu/faq/stem-cells
Canadian Cancer Society
Stem cell transplant
A stem cell transplant replaces stem cells. It is used when stem cells or bone marrow have been damaged or destroyed by disease, including some types of cancer, or by high doses of chemotherapy or radiation therapy used to treat cancer.
https://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/stem-cell-transplant/?region=on
Welcome to the UC Davis stem cell program
For patients and families suffering from chronic disease or injury, the promise of stem cell therapies offers great hope. UC Davis is a leader in advancing that promising goal.
It has brought together physicians, research scientists, biomedical engineers and a range of other experts and collaborative partners to establish the UC Davis Institute for Regenerative Cures, a facility supported by the California Institute for Regenerative Medicine.
Brings leadership in stem cell research, patient applications, and training to you through our state-of-the-art global network of companies. Our mission is to enable physicians to make the benefits of stem cell medicine a reality for patients around the world.
https://health.ucdavis.edu/stemcellresearch/
Stem Cells for Cystic Fibrosis Therapy
Stem cells are a special type of cell that can divide and produce many other cell types. Scientists are studying how adult stem cells could be used to treat cystic fibrosis.
https://www.cff.org/Research/Research-Into-the-Disease/Restore-CFTR-Function/Stem-Cells-for-Cystic-Fibrosis-Therapy/
..BUSINESS OPPORTUNITY
We are offering an Integrated Solution of a Turn Key State of The art Stem Cell processing center allowing our clients to position themselves in the forefront of the fastest growing sector in the Medical Industry.
Our Clients will be able to conduct research and perform highly advanced stem cell procedures. The project represents a self-reinforcing vertical enterprise.
..We’ll train you and your staff on the full business operations of running a regenerative medicine practice, and advise you on how to best handle patients.
Profit Sharing On Events In Your Territory
We’ll share the profits with you on certain events that will be held in your membership territory.
On-Site Medical Procedure Training
http://stemcellslab.net/business-opportunity/
https://www.nanalyze.com/2019/08/top-10-companies-longevity
Loma Linda Hospital ‘Effecively Cures’ Girl Using Stem Cells Transplanted from Dad, Report Says
https://sicklecellanemianews.com/2019/04/18/california-hospital-effecively-cures-girl-using-stem-cells-transplanted-from-dad-report-says/
..The decision to expand its corporate presence into Cancun was based on the rising demand for patients seeking stem cells treatments at the group’s facilities already established in Cancun. The GSCG maintains two regenerative medicine operations in Cancun, which include medical facilities and a stem cells laboratory.
..GSCG’s Cancun facilities provide state-of-the art options for patients seeking stem cells treatments that are currently not available in the US. While these protocols and products are currently unavailable within the US’s borders due to regulations, the Cancun center has still adopted the FDA’s frameworks for safe and effective regenerative medicine products and therapies.
..With its office located near its medical center and laboratory, the GSCG team can more closely monitor the treatment process from the time the patient arrives at the Cancun airport to the time their treatment is complete and they return to the US.
http://www.stemcellsgroup.com/the-groups-new-permanent-office-in-cancun-will-help-streamline-the-patient-experience-by-providing-holistic-support-throughout-the-treatment-process/
..LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers
www.stemcellsgroup.com has opened two new stem cell offices, one in Valencia, Spain and one in Cochabamba, Bolivia. This brings the total number of global Stem Cell centers to 36 worldwide in 27 countries.
The new clinic in Valencia will be the group’s third operation in Spain and the fourth in Europe
https://www.globenewswire.com/news-release/2019/06/12/1867610/0/en/LAHO-Global-Stem-Cells-Group-Announces-Opening-of-Two-New-Stem-Cell-Centers.html
$LAHO GSCG each division worth pennies-Multi-Billion per sector..Combined??$$
$LAHO GSCG selected for clinical trials.
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://www.issca.us
..Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Anoop Chaturvedi is the CEO of World Antiaging Network, the First International peer to peer platform of Antiaging physicians, the Founder President of Antiaging Medicine and Research
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
http://www.stemcellsgroup.com/advisory-board/
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Global Stem Cells Group Takes Part in Clinical Trial.
..Up to 20 centers in the United States have will be invited to enroll in the study.
..Faculty members from the Global Stem Cells Group will be treating subjects enrolled in the study. Global was chosen to participate in this study due to its unique stature as a leader in regenerative medicine. The group is known for its comprehensive support of regenerative medicine solutions, starting with education, patient treatment and research and ending with the manufacturing and distribution of equipment for regenerative medicine practitioners.
http://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
Kipp Van Camp, DO Chief Operating Officer
..He will be published in the Association of American Physicians and Surgeons this winter for his research and treatment of Alzheimer’s disease with stem cell therapy.
https://www.435mag.com/ideal-health-regenerative-medicine/
https://www.idealhealthus.com/our-practice
Chief Operating Officer
Dr. Van Camp is the host of the popular “Doctor’s Orders” Radio show, aired in more than 50 markets nationwide and growing.
https://www.stemcelltraining.net/management/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
GSCG..preparing to launch Progenikine™..
..Developed in conjunction with Patrick Pennie, Emcyte CEO, and Maritza Novas Director of Research and Development for Global Stem Cells Group, Progenikine fuses elements from Emcyte systems with the Global Stem cells Group SVF protocols. The kit can provide a low cost, rapid and
simple alternative to traditional methods of isolating ASCs, particularly when smaller quantities are needed.
“We’re excited to launch the Progenikine kit, the newest product designed to help Global Stem Cells Group’s fulfill its mission to provide accessible products to our member clients,” says Benito Novas, CEO of Global Stem Cells Group. “These are the milestones that bring us closer to ensuring that more patients will be able to gain access to stem cell therapies.”
https://www.stemcelltraining.net/tag/stem-cells/page/6/
$LAHO GSCG future of medine$$$$
$LAHO addressed in my post no disagrement, Edgar is corporate actions not PR, though PR can drop on holiday.
$LAHO Correct once more. 3000 filings per day but not PR. I was consolidating all-forms filed in totality without seperation of channel consideration.
The EDGAR database provides free public access to corporate information, allowing you to research a public company’s financial information and operations by reviewing the filings the company makes with the SEC. You can also research information provided by mutual funds (including money market funds), exchange-traded funds (ETFs), and variable annuities.
https://www.sec.gov/oiea/Article/edgarguide.html
What is EDGAR?
EDGAR is the Electronic Data Gathering, Analysis, and Retrieval system used at the U.S. Securities and Exchange Commission (SEC). EDGAR is the primary system for submissions by companies and others who are required by law to file information with the SEC.
Containing millions of company and individual filings, EDGAR benefits investors, corporations, and the U.S. economy overall by increasing the efficiency, transparency, and fairness of the securities markets. The system processes about 3,000 filings per day, serves up 3,000 terabytes of data to the public annually, and accommodates 40,000 new filers per year on average.
https://www.sec.gov/edgar/aboutedgar.htm
$LAHO GSCG future of medicine$$$$
$LAHO Correct sir MM followed..Per Sec guideline..
Sec
DGAR Filer Information:
Calendar of Federal Holidays in 2019
The Federal Government will be closed in observance of the following holidays. The EDGAR system will not receive, process, or accept filings on these days. The SEC mailroom that receives paper filings will also be closed. However, EDGAR filings that have already been posted to the website will be accessible as usual.
https://www.sec.gov/info/edgar/fedholiday.htm
I believe those filed takes about 3-5 days give or take. I have seen news on weekends.
News or no news no differnce it will come in due time.
$LAHO GSCG no stopping blockchain or stemcells, best to embrace$$$
$LAHO No such filing, not permissible until current nor required.
GSCG opened Cancun facility suggesting funds and or established business line.
To meet eligibility of Nasdaq I believe there is a wait period 1-2 year and Revenue Requirement for small cap
Unlikely considering notes swapped per prior filings.
3D Bioprinting Market To Reach USD 4.40 Billion
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
The International Space Station Has a New Partner in Regenerative Medicine
..Scientists will look to exploit the unique behavior of stem cells in microgravity to improve cell-based therapies for a variety of diseases and impairments, including traumatic brain injury and type I diabetes.
https://3dprint.com/252388/the-international-space-station-has-a-new-partner-in-regenerative-medicine/
NASA and Techshot Trying To 3D Print Organs In Space
https://www.nasa.gov/mission_pages/station/research/news/spx18-research/
INKREDIBLE 3D BIOPRINTER
https://www.adimarket.net/product-category/cellular-and-tissue-based-products/
..“Our objective is to bring this cutting-edge 3D bioprinting technology to scientists and regenerative medicine researcher throughout Lain America,” says Global Stem Cells Group founder and CEO Benito Novas. “CELLINK has revolutionized tissue engineering with its range of bioprinters, and we’re excited to make this process available to scientists and regenerativ
e medicine researchers in Mexico, Central America, and South America.
https://www.stemcellscourse.com/global-stem-cells-group-to-represent-cellink-3d-bioprinting-technology-in-latin-america/
Global Stem Cells Group to Represent CELLINK 3D Bioprinting Technology in Latin America
http://www.stemcellsgroup.com/tag/stem-cell-research/
$LAHO GSCG each division worth pennies..each market segment Billions,,combined?$$
$LAHO One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025.
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
BOFA..forecast..balloon $610 billion ..'Extraordinary' Breakthroughs In Anti-Aging Research 'Will Happen Faster Than People Think'
https://www.forbes.com/sites/robinseatonjefferson/2019/08/26/how-extraordinary-breakthroughs-in-anti-aging-research-will-happen-faster-than-people-think/#6f7b016033dd
Our Company has been certified by Independent and international reviewers, we have achieved the highest possible standard and quality of services
STEM CELL TECHNOLOGY
PATENT 2 STEM CELL MASS PRODUCTION
PATENT 3 STEM CELL CULTURE MEDIA
http://stemcellslab.net/about/patents-and-certifications/
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Doctors and scientists are excited about stem cells because they could help in many different areas of health and medical research. Studying stem cells may help explain how serious conditions such as birth defects and cancer come about. Stem cells may one day be used to make cells and tissues for therapy of many diseases. Examples include Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes, and arthritis.
https://medlineplus.gov/
Stem Cell Transplants in Cancer Treatment
Stem cell transplants help restore blood-forming stem cells in people who have had theirs destroyed by certain cancer treatments.
Credit: National Cancer Institute
Stem cell transplants are procedures that restore blood-forming stem cells in people who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy that are used to treat certain cancers.
https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
GSCG.. Authorized Distributor of GMTN Exosome Injection and Other Biological Products..
Scientists believe that stem cell research can be used to treat medical conditions including Parkinson's disease, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis and rheumatoid arthritis.
http://www.stemcellsgroup.com/global-stem-cells-group-named-authorized-distributor-of-gmtn-exosome-injection-and-other-biological-products/
$LAHO GSCG each division worth pennies..Combined????$$$
$LAHO thanks my friend followed back. More Stem proofs..
..How Can Stem Cell Treatment Help?
Stem cells may be able to reverse paralysis due to injury or stroke. The general mechanism is:
Doctors remove stem cells from the patient’s body or a donor’s body.
They culture those cells in a lab until they’ve reached a certain number, deemed large enough to prove effective when introduced into the patient’s body.
When that number is reached, physicians prep the patient and inject those stem cells into the affected part of the paralyzed victim.
They then observe the patient over the coming days, weeks, and months to check for reaction and monitor progress.
So, does it work? Some studies say yes.
Stem cells will 'change medicine forever,' says UB surgeon-turned-stem cell engineer
I gave up my whole surgery career to work on stem cell research. And I was crazy about a surgical career, too, but when I started working on stem cells, I saw great potential in its future and I realized that's what I wanted to do full time.
..The potential is infinite with stem cells. It's regenerative medicine. Nearly all chronic disease in medicine could be addressed by stem cells. They will change medicine forever. Look at all the different pharmaceuticals patients are prescribed, sometimes for many years, ranging from blood thinners, to drugs to treat chronic pain. However, they are not ideal for treating chronic diseases, because they target a single molecular pathway, whereas curing chronic diseases would require targeting a multitude of pathways.
https://medicalxpress.com/news/2018-10-stem-cells-medicine-ub-surgeon-turned-stem.amp
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://time.com/5394912/stem-cell-treatment/?amp=true
Can Stem Cell Therapies Help ALS Patients?
..The future of stem cell therapies for ALS
It’s clear from speaking with Svendsen, that he is optimistic about the future of stem cell-based therapies for ALS. Scientists still need to unravel the actual causes of ALS. But the experimental stem cell treatments currently in development, including Svendsen’s, will hopefully prove effective at delaying disease progression and give ALS patients more quality years to live.
https://blog.cirm.ca.gov/2017/10/09/can-stem-cell-therapies-help-als-patients/amp/
$LAHO GSCG future of medicine$$&$
$LAHO Stem Cells Paralysis cure, and cure for incurable’s..
Kusachi recalled of the incident that damaged his spinal cord and left him mostly paralyzed.
..Kusachi soon joined a clinical trial for a new treatment for spinal cord injuries called Stemirac. Researchers at Sapporo Medical University drew fluid from his bone marrow, isolated a type of stem cell found there, multiplied the cells in the lab, and infused them back into his bloodstream intravenously. The day after the treatment, Kusachi dramatically improved. “That was a real surprise to us,” said Toshihiko Yamashita, an orthopedic surgeon at the university. “In the afternoon, he could rise up from his bed and sit. In the evening, he was getting around in a wheelchair.”
The improvement continued. Seven months after the injection, Kusachi left the hospital under his own power. Today, although control of his hands and feet is still clumsy, he cooks, drives, and teaches math online — all thanks, he says, to Stemirac.
The Japanese health ministry approved Stemirac last December, and the treatment is now available to the Japanese public,
https://undark.org/article/new-japanese-stem-cell-treatment-debate/
Pioneering Stem Cell Trial Seeks to Cure Babies Before Birth
..The disease, which has no cure, is usually fatal for a developing fetus.
But while still in her mother’s womb, Elianna received a highly daring treatment. Doctors isolated healthy blood stem cells from her mother and injected them through a blood vessel that runs down the umbilical cord. Four months later, Elianna was born with a loud cry and a glistening head of hair, defying all medical odds.
https://singularityhub.com/2018/06/13/pioneering-stem-cell-trial-seeks-to-cure-babies-before-birth/amp/
MEET THE ONLY PERSON TO BE CURED OF HIV
..He’s the only person in history who has been treated successfully for HIV—and it is all thanks to stem cells.
https://americansforcures.org/patient_story/tim-brown-hiv-aids-cured-stem-cells/
To date two persons were cured of Hiv using stem cells.
Chasing a Cure for Lung Disease With Stem Cells: A Conversation With Finn Hawkins
You can take a cell from your skin, explained Darrell Kotton, MD, grow it in a dish, and then reprogram it to make a stem cell capable of becoming any cell type in the body. If you could succeed in turning those stem cells into functioning lung cells, Kotton went on, it could resolve a major bottleneck in pulmonology research — limited access to tissue samples — and accelerate a cure for cystic fibrosis and other diseases
https://www.bmc.org/healthcity/research/chasing-cure-lung-disease-stem-cells
$LAHO Future of Medicine, any patient any cure$$$
$LAHO Anytime my friend, GSCG will set record straight!!
Stanford..neurologist and longevity researcher Thomas Rando, MD, PhD and his colleagues have found that adult stem cells (those that hang around in mature tissues to facilitate tissue repair) have a surprising ability to notice, and respond, to damage in distant parts of the body. The researchers termed the response an "alert" state; the cells are no longer resting deeply, but are also not yet committed to possibly unnecessary action. (As I was writing our release, I kept envisioning the stem cells like dogs frozen in a point, waiting for further movement or instructions.)
https://scopeblog.stanford.edu/2014/06/02/alert-stem-cells-speed-damage-response-say-stanford-researchers/
One of the predictions he listed was that by 2030, "humanity will have achieved Longevity Escape Velocity for the wealthiest."
https://www.dw.com/en/what-if-billionaires-could-live-forever/a-42840013
GOLDMAN SACHS..Smart Money Is Piling Into Regenerative Medicine
Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine
The Goldman report discusses Samumed, a private RM company. With $300 million in funding,it’s valued at a staggering $12 billion Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.google.com/amp/s/www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/amp/
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Hedgefund Mesoblast!
https://whalewisdom.com/stock/mblty
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
Stem Cells Lead To A Genuine Miracle Cure
https://www.forbes.com/sites/stevensalzberg/2017/11/13/transgenic-stem-cells-lead-to-a-genuine-miracle-cure/#6a1d8a4d5c52
Exosomes, metastases, and the miracle of cancer stem cell markers
https://www.ncbi.nlm.nih.gov/pubmed/31030373
GSCG..Adimarket..exosomes..FDA APPROVED
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
Brings leadership in stem cell research, patient applications, and training to you through our state-of-the-art global network of companies. Our mission is to enable physicians to make the benefits of stem cell medicine a reality for patients around the world.
http://www.stemcellsgroup.com/
$LAHO GSCGImproving quality of life, Trillion dollar industry$$$
$LAHO GSCG.. How stem cell treatments can make medicine effective and affordable
Throughout history, healthcare has gradually transformed from a mystical art into a defined science. While there are still challenges to be faced, life-saving stem cell treatments are revolutionising the industry
..in economic terms, it’s estimated that aspirin helps global healthcare providers save as much as $700bn (€594.4bn) per year.
..Stem cells are the clearest opportunity to provide humans with a potentially life-saving solution in the future..Furthermore, the combination of private and public healthcare is the subject of current research, as is the development of new solutions and therapies...
..They heal us after illness or injury, and defend our bodies against harsh external conditions. They do this by renewing and regenerating lost cells and tissues. Bone marrow, for example, has been used to treat certain blood cancers, and we now understand that it is the haematopoietic stem cells within the bone marrow that contribute to this success.
However, the shortage of bone marrow and genetic diversity has pushed us to find other sources of these haematopoietic stem cells, namely in peripheral blood and umbilical cord blood. Today, stem cells from umbilical cord blood are routinely used to treat approximately 80 medical conditions including leukaemia, lymphoma, immune disorders and anaemia. However, affordability and accessibility remain a challenge.
https://www.europeanceo.com/business-and-management/how-stem-cell-treatments-can-make-medicine-effective-and-affordable/
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
..According to the American Cancer Society, one in three people will have cancer at some point in their lifetime. Surgical removal of tumors can be curative, but many tumors form so close to major blood vessels that surgery becomes challenging or impossible. That means the vast majority of cancer patients have to endure chemotherapy. Because chemotherapy can’t distinguish cancerous cells from healthy ones, it can cause a range of adverse side effects.
..Gene editing is widely regarded as the future of treating
..Leveraging the combined expertise of the College of Natural Resources’ Forest Biotech Group (FBG) and the College of Agriculture and Life Sciences’ CRISPR lab, FBG Director Jack Wang and CRISPR pioneer Rodolphe Barrangou have discovered how to edit tree stem cells without using added DNA. Forests and forest products are a $700 billion global industry and a critical part of North Carolina’s economy —
https://research.ncsu.edu/blog/2019/07/chancellors-innovation-fund-helps-turn-nc-state-research-into-real-world-solutions/
GLOBAL STEM CELLS GROUP AND WESTMINSTER UNIVERSITY IN KOREA AWARD CERTIFICATES
..Dr. Paul In Chan Chung personally handed each student his or her certificate.
“This was a monumental recognition ceremony for students who have gone above and beyond with regards our regenerative medicine lab-setting course,” said Novas. “We need more people to be committed to furthering the effects of stem cell medicine, and this batch of students is well on their way to contributing to the future of the industry.”
https://www.stemcelltraining.net/global-stem-cells-group-and-westminster-university-in-korea-award-certificates/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150827110
Adimarker Llc imports from N-biotek, Inc. in South Korea through the port of Los Angeles, California
..DESCRIPTION CENTRIFUGES FOR LABORATORY USE 8421.19-1000
..SUPPLIER N-BIOTEK, INC.
..40 FOOT CONTAINER South Korea
https://www.importgenius.com/importers/adimarket-llc
Adimarket announce agreement.. N-Biotek to offer the Total Solution highly manipulated stem cell culture expansion lab, complete with equipment, training, facilities, stem cell processing center, clean rooms, project plan and more- a total turnkey lab solution for emerging stem cell businesses and industry professionals.
The announcement marks a new chapter in GSCG’s ongoing expansion, and commitment to bring stem cell therapies to
..Until now, Admarket has been GSCG’s online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals, offering basic tools and products to facilitate in-office stem cell procedures. However, through N-Biotek, Adimarket now offers the Total Solution labs and all the accoutrements. From planning to building the facility, to training and consultation, Total Solution users are equipped in every way possible to walk in and begin using their fully-equipped biotechnology lab in short order.
https://www.stemcelltraining.net/total-solution/
$LAHO GSCgScience, Reason and logical approach$$$$
$LAHO Every year about 600,000 Americans get a knee replacement, a number that could rise to 3 million by 2030. Until recently, treatment options were either temporary or surgical.
Now, in numerous cases, stem cell therapy for knees is reducing pain and repairing cartilage. As a result, many people have been able to improve their quality of life and avoid surgery.
Side effects
Stem cell treatment for knees is noninvasive and rarely painful. Side effects are minimal.
https://www.healthline.com/health/stem-cell-therapy-for-knees#treatment
Stem cells: Creating a cure-all
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Stem Cells and Health Advances: Where Are We Now?
..It worked. Kuehl sees better
Stem Cells: 30 Years and Counting
Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents say all this groundwork is finally coming to fruition, others call progress slow and plodding.
.."I would say the pace of things has been much faster than I would have predicted," says Andy McMahon, PhD, a W.M. Keck provost and university professor at the University of Southern California.
In comparison, Wells says, prescription drugs often take 15 years to progress from research stages to market.
https://www.webmd.com/brain/news/20190812/stem-cells-and-health-advances-where-are-we-now
$LAHO GSCG inproving quality of life, non invasive, no nasty pills, less side effects and much cheaper than organ or invasive surgery. Everyone knows someone who needed knee replacement before stem therapy, well inproved vision, curing leukaemia, no better place to invest$.
$LAHO For Consideration$$$$
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150848275
Stem Cells!
1 The cure for anything ..*Harvard.
2 GSCG opened new facility-facilities, not financially crippled in good standing.
3 Trillion dollar market... without-before allocating Pharmacy monies as follows:
(a) $1Trillion dollar failed war on cancer
(b) $700B Alzaimers failed treatment
(c) cures anything (what numeric dollar figure is appropriate here)?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150842273
4 blockchain Lans Holding also Trillion dollar market, IBM programing new SS, crypto etc..
5 expansion and growth individual sectors of Stem industry
6 buyout always an option
7 $3.2 trillion or 1/3 US GDP allocated in health 1/3 towards of that regenerative care.
8 and so much more this post would get to long, alarming third party evidence from experts.
9 Hundreds of billions in mergers & Acquisitions second largest ever, not including Goldman Sachs or Bofa!
10 Other penny runners with similiar share structure was not diversified or vast market, not appropriate test.
11 Banks printing ability directly buying stocks first time in history market meltup.
The power to print money.
Trillions of dollars – on-demand.
.For the first time in history - central banks are now funneling trillions of dollars, directly into the stock market.
https://orders.thecrux.com/chain?cid=MKT376375&eid=MKT417624&step=start&assetId=AST90728&page=1
US health..spending increased 5.8%..3.2 Trillion
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150854718
Harvard* Any Patient With Any Disease
https://hsci.harvard.edu/news/any-patient-any-disease
Several billionaires, most of them Californians, have been funding firms involved in developing life-extension technologies. What if they succeed? What if billionaires alive today live indefinitely and get ever richer?
One of the predictions he listed was that by 2030, "humanity will have achieved Longevity Escape Velocity for the wealthiest."
..By replenishing our reservoir of stem cells, nature's repair kit, on an ongoing basis, we can augment our longevity,
Some of the more recognizable names who have been putting money into such efforts: Larry Ellison (founder of Oracle), Larry Page and Sergey Brin (founders of Google), Jeff Bezos (founder of Amazon), and Peter Thiel, cofounder of PayPal and Palantir Technologies.
https://www.dw.com/en/what-if-billionaires-could-live-forever/a-42840013
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150850741
..second-largest acquisition in the history of venture capital
AbbVie, a major biopharmaceutical company, just picked up biotech startup Stemcentrx in a deal that's worth up to $10.2 billion.
https://www.businessinsider.com/why-abbvie-acquired-stemcentrx-2016-4
$LAHO best wishers to floridians.. we are fortunate to have be part of GSCG$$
$LAHO I agree GSCG Lans Holding is very transparent will set records IMO.
I recall Insys therapy (MK Cap $11M) ran to $11 (high $38) Fda approved fent spray.. what a joke..currently Yield sign, Sec Dilenquent, chap11 Banktuprcy, $.15.
GSCG Investor Relations
..We are committed to balancing competitive pricing and providing solid economic gains for our shareholders.
..We pledge to adhere to the highest standards of integrity on behalf of our customers, our stockholders, and the world. We have created the optimal corporate structure to realize Global Stem Cell Group’s long-term potential, and we have established the appropriate financial controls and management oversight of our internal processes.
http://www.stemcellsgroup.com/investor-relations
$LAHO GSCG deserves to be well beyond $.15 considering the 1 Trillion market availability.